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ABSTRACT 
 
Roles of nitric oxide and shear stress in the regulation of microvessel permeability 
in intact rat mesenteric venules 
Sulei Xu 
Mechanical forces have been indicated to play important roles in the regulation of 
inflammatory cell interaction with endothelium resulting in localized leakage formation and 
contributing to many disease-associated microvascular dysfunctions. However, most of the 
mechanical force related studies were conducted in vitro. The underlying mechanisms are 
still controversial. There is a need to investigate how shear stress regulates the endothelial 
cell (EC) signaling and related vascular barrier function using intact microvessels with 
experimental conditions closely replicating in vivo situations. The overall aim of my 
dissertation is to understand the molecular and cellular mechanisms of how shear stress 
and nitric oxide (NO) regulate microvessel function under physiological and pathological 
conditions. Studies were conducted on individually perfused intact rat mesenteric venules. 
It is well known that shear stress is one of most important regulators in stimulating 
endothelial cells to produce NO. NO, in addition to being a potent vasodilator, has also 
been considered a “double edged sword”-mediator in inflammation. Under basal 
conditions, it prevents leukocyte and platelet adhesion, whereas under inflammatory 
conditions, the inflammatory mediator-induced excessive NO production contributes to 
permeability increases. In Chapter 2, we investigated the roles of endothelial basal NO 
production in leukocyte adhesion and adhesion-induced changes in microvessel 
permeability. The results indicated that the application of the eNOS specific inhibitor, 
caveolin-1 scaffolding peptide (CAV), caused reduction of basal NO and promoted ICAM-
1-mediated leukocyte adhesion through Src activation-mediated ICAM-1 phosphorylation. 
Also, CAV-induced leukocyte adhesion was uncoupled from leukocyte oxidative burst and 
microvessel barrier function, unless in the presence of a secondary stimulation. 
In Chapter 3, we investigated the roles of shear stress (SS) in the regulation of 
microvessel permeability and its related EC signaling involving blood cells in individually 
perfused intact microvessels. Our results demonstrated that in response to a sudden 
change of SS, transient shear magnitude-dependent increases in EC [Ca2+]i occurred only 
in vessels perfused with whole blood or perfusate containing RBCs, which was correlated 
with EC gap formation illustrated by fluorescent microsphere accumulation. Carbenoxolone, 
a Pannexin 1 inhibitor, significantly reduced shear magnitude-dependent ATP release from 
RBCs and also abolished SS-induced increases in EC [Ca2+]i and EC gap formation. 
Meanwhile, both plasma and whole blood perfusion induced shear magnitude-dependent 
NO production and eNOS-Ser1177 phosphorylation. 
It is unknown how EC sense SS, but the Glycocalyx (GCX), a layer of proteoglycans 
covering the endothelium, has been implicated as a mechanical sensor for changes in SS 
in vitro.  The objective of chapter 4 is to identify the changes in GCX in microvessels of 
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streptozotocin-induced diabetic rats and evaluate the associated changes in sensing SS 
and SS-induced NO production in individually perfused venules of diabetic rats. Our results 
indicated that the impaired GCX in diabetic microvessels enhances EC response to 
mechanical force and potentiates NO production and EC responses to ATP, resulting in 
enhanced endothelial gap formation.  
Advances in micromanufacturing and microfluidic technologies have enabled a variety 
of insights into biomedical sciences while curtailing the high experimental costs and 
complexities associated with animals and in vivo studies. In Chapter 5, we presented and 
discussed our research work in creating engineered microvessels using a microfluidic 
platform and demonstrated the formation of the microvascular network in vitro and validated 
the key features that have been observed in microvessels in vivo.  In our future studies, 
this may provide us a novel platform for studying spatial and temporal change of shear 
stress in the regulation of microvessel function in a close in vivo situation.  
In conclusion, we revealed the role of shear stress and NO in the regulation of 
endothelial cell signaling and microvessel permeability in vivo, involving blood and non-
blood components. The results also suggest the potential in using a microfluidic device in 
studying the physiological microvessel function. 
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INTRODUCTION 
The vascular endothelium lining the interior surface of vascular wall maintains vascular 
homeostasis by modulating a variety of vascular functions including vascular tone, 
angiogenesis, vascular remodeling, and inflammatory responses. As a semi-permeable 
barrier, endothelium is particularly important in regulating the vascular permeability by 
controlling the exchange of macromolecules and fluid between the blood and interstitial 
space. Under physiological conditions, the increased vascular permeability enables the 
extravasation of plasma proteins, immunoglobulins, and others, which serves as one of the 
important host-defense functions. However, unchecked vascular permeability increase can 
lead to protein-rich tissue edema, chronic inflammation, and organ dysfunction. 
Atherosclerosis is one of those pathologies. It has been demonstrated in vivo that 
atherosclerosis patch is co-localized with sites of elevated endothelial permeability.1, 2  
Endothelial dysfunction is well recognized as the initial step in the atherosclerotic 
process.3, 4 A major vasoactive substance released by the endothelium is nitric oxide (NO), 
originally named as endothelium-derived relaxing factor (EDRF). NO has been recognized 
to play a pivotal role in maintaining normal vascular functions. Dysregulated NO production 
or eNOS (endothelial NO synthase) activity has been proposed as a major mechanism of 
endothelial dysfunction, contributing to atherosclerosis. However, in addition to being a 
critical mediator in maintaining vascular homeostasis, NO has also been considered as a 
“double edged sword”-mediator in inflammation. It has been reported that excessive NO 
production induced by inflammatory mediators contributes to increased microvessel 
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permeability, leading to tissue edema and organ dysfunctions. 5-7 Basal NO production, on 
the other hand, has been reported to prevent leukocyte adhesion and platelet aggregation 
on the vessel wall, therefore, playing an anti-inflammatory role.8-10 In Chapter 2 of this 
dissertation, by using caveolin-1 scaffolding domain peptide, an endothelial nitric oxide 
synthase (eNOS) specific inhibitor, we investigated the role of and underlying mechanisms 
of endothelial basal NO in preventing leukocyte adhesion and adhesion-induced increases 
in microvessels permeability. 
Wall shear stress (SS) is the tangential force exerted per unit area of blood-endothelium 
surface. Disturbed shear stress has been reported to promote atherosclerosis and 
inflammation in the vessel wall.11, 12 Postcapillary venules are the dominant sites for the 
occurrence of inflammation and increased microvessel permeability. The role of shear 
stress in the regulation of venular microvascular barrier function, and how the endothelium 
senses the change of SS under either physiological or pathological, in particular under 
diabetic conditions, have not been well explored so far. In Chapters 3 and 4 of this 
dissertation, studies were conducted to understand the cellular and molecular mechanisms 
of how SS regulates microvascular barrier function under physiological and diabetic 
conditions in intact microvessels. In Chapter 3, we investigated the mechanisms of SS-
induced changes in microvessel permeability under physiological conditions. We proposed 
that the glycocalyx on the endothelial surfaces acts as a mechanical sensor of SS to cause 
alterations in EC [Ca2+]i, and NO, thus contributing SS-induced changes microvessel 
permeability. In this study, we measured EC NO, [Ca2+]i changes and microvessel 
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permeability in response to quantitative alterations of SS in intact rat mesenteric venules. 
The glycocalyx has been implicated as a mechanical sensor of changes in SS. A variety of 
diseases such as endotoxemia and hyperglycemia have been reported to cause damage 
to the glycocalyx coating on the EC surface.13, 14 However, little is known about the potential 
effect of degraded glycocalyx on SS-mediated vascular function and how the altered 
vascular function playing a role in the pathogenesis of these diseases. Therefore, in 
Chapter 4, studies were conducted to investigate the role of impaired glycocalyx 
(mechanosensor) in microvessel barrier dysfunction in diabetes by evaluating the 
ultrastructural changes of EC glycocalyx in the vascular wall and the correlated alterations 
in SS-induced EC signaling, as well as microvessel permeability using fluorescence and 
electron microscopic approaches.  
To investigate the effects of spatial and temporal variations of SS on endothelial 
vascular function is a big challenge for us in our study. In vivo microvasculature has 
unbelievably heterogeneous and complex geometries. It is difficult for us to define and find 
a certain angle of bifurcated segments in each experiment. Also, due to the time limitation 
of the in vivo experiments, it is difficult for us to observe the effect of long term SS on 
endothelial cell signaling and morphological changes, which usually requires more than 48 
hours shear exposure. Fortunately, by using up-to-date microfluidic devices lined with 
primary human umbilical vein endothelial cell, which recapitulated microvessels with fixed 
geometric pattern, we successfully investigated the long term SS effect on endothelial cell 
morphology, and how the changes in morphology is associated with changes in cellular 
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signaling. In Chapter 5, we investigated changes in vascular endothelial F-actin and VE-
cadherin to different levels of SS. Also, we quantitatively measured changes in EC [Ca2+]i 
and NO production to adenosine triphosphate (ATP). 
In summary, the dissertation mainly focuses on investigating the mechanisms of shear 
stress-mediated changes in microvascular permeability in vivo and in vitro, involving blood 
and non-blood components 
 
 
 
 
 
 
 
 
 
 
  
 
 
6 
 
 
 
 
BACKGROUND AND SIGNIFICANCE 
MICROVESSEL PERMEABILITY  
General aspect 
Under physiological conditions, the semi-permeable property of vascular wall 
enables the exchange of gases, ions, and solutes across the vessel wall through 
endothelial transport. In general, endothelial transport can be divided into paracellular and 
transcellular pathways. Passive diffusion through the endothelial paracellular route has 
been found as a dominant exchange pathway for fluid and hydrophilic solutes with 
molecular radii of up to 3 nm.15 On the other hand, the transcellular vesicular pathway is 
responsible for the active transport of macromolecules, such as albumin. In order to 
quantitatively define the microvessel exchange property, microvessel permeability 
coefficients, which reflect and represent the barrier function of microvascular walls to a 
specific substance, were adopted in various experimental measurements as shown in 
Table 1. 
Table 1 Membrane permeability coefficients  
Permeability coefficient Symbol 
Hydraulic conductivity Lp 
Diffusional permeability Pd 
Solvent drag (ultrafiltration) σf 
Osmotic reflection coefficient σd 
 
In the studies of this dissertation, the hydraulic conductivity (Lp), which represents the fluid 
permeability across the vessel wall was evaluated in individually cannulated intact venules. 
The Lp was quantitatively measured by calculating the volume flux of water across the 
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vessel wall under a certain driving force of pressure difference. It is well illustrated in the 
Starling Equation. 16   
Jv = (LpS)[(Pc – Pi) – σ(πc – πi)] 
 
Jv: Volume flux of fluid; Lp: Hydraulic conductivity; S: Surface area; Pc:Capillary fluid 
hydrostatic pressures; Pi: Interstitial fluid hydrostatic pressures; πc: Capillary colloid osmotic 
(oncotic) pressures; πt:Interstitial colloid osmotic (oncotic) pressures; σ:Osmotic reflection 
coefficient of vessel wall (0 if membrane is fully permeable to transported molecular species 
and 1 if the membrane is impermeable). 
Various experimental preparations in measuring permeability coefficients  
Microvascular permeability coefficients can be measured from perfused whole 
organs, single cannulated microvessels, to monolayers of cultured endothelial cells. They 
all have their advantages and disadvantages.  
Permeability coefficient measured in whole organs, isolated tissues or whole animals, 
involves minimal interference with experimental handling, which is closest to the native 
situation in vivo.  However, those studies usually overlook changes in transmural pressure 
gradients, changes in exchanging surface area, and presence of blood cells in the 
regulation of vascular permeability. Especially, in those animal disease models, the 
changes of cell and vascular morphology can greatly affect hemodynamic alternation, 
which usually results in inconclusive measurements. 
The use of in vitro monolayers of cultured ECs allows the investigation of cellular and 
molecular mechanisms of the regulation of endothelial permeability. However, cultured 
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endothelium has been reported to be a pro-inflammatory endothelial phenotype in 
comparison to the native endothelium in vivo. 17 Also, multidimensional protein 
identification revealed that 41% of proteins expressed in vivo were not detected in vitro, 
indicating that distinct in vivo protein expression is apparently regulated by the tissue 
microenvironment and cannot yet be duplicated in standard cell culture.18 It raises serious 
concerns when directly applying the knowledge we gained from in vitro to those in vivo.   
Using a single cannulated microvessel in the study of microvessel permeability is the 
main technique we adopted in this dissertation. The primary advantages of this approach 
is that it allows the direct and precise control of the conditions of perfusion for a defined 
segment of microvessel while directly measuring the real time changes of the vessel 
surface area, the difference in pressure, and concentration of solutes across the vessel 
walls. The limitations of studies on single vessels are i) experimental preparations are 
restricted to several convenient vessel types, such as mesenteric vessels and cremaster 
vessels; ii) there is an experimental duration limit for these preparations and iii) each 
experiment preparation is also quite time consuming. 
NITRIC OXIDE (NO), MICROVESSEL PERMEABILITY & LEUKOCYTE ADHESION 
NO has been recognized as an important cardiovascular signaling factor that is not 
only a potent vasodilator regulating vascular tone and blood pressure, but also plays an 
important role in the regulation of microvessel permeability and leukocyte adhesion. 8, 19-
22 NO is biosynthesized from L-arginine through the enzyme NO synthase (NOS). There 
are three main isoforms of the enzyme called neuronal NOS (nNOS), inducible NOS 
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(iNOS), and endothelial NOS (eNOS). Among those, eNOS has been found to be the 
dominant constitutive enzyme responsible for NO production in the cardiovascular system. 
NO and microvessel permeability 
For decades, a growing body of literature suggested that NO modulates the 
movement of fluid and protein from the vasculature. However, the results obtained from 
whole organ, single vessel, and endothelial monolayer studies are often not consistent.  
Numerous experimental evidence suggest that endogenous NO increases microvascular 
permeability while an equal amount of evidence indicates that NO inhibits increases in 
microvascular permeability. Since the early 1990s, Kubes et al. and others showed that 
nonselective NO synthase inhibition increased vascular leakage in the presence of blood, 
suggesting a protective role of NO in barrier function. 8, 23-25 Almost at the same time, 
others showed that inhibition of NO prevented permeability increases in response to 
inflammatory mediators and other physical stimulates.7, 22, 26-35 Those conflicting results 
were derived from different experimental approaches, organs, tissue conditions, and 
animal species. Our previous findings showed that excessive NO production induced by 
inflammatory stimuli is responsible for the increases in microvessel permeability 26-29. Our 
present study in this dissertation was to investigate the role of basal NO production in the 
regulation of microvessel permeability using the same experimental preparation. 
Combined, these two results revealed the dual actions of NO on endothelial functions at 
basal and inflammatory conditions, which provides a unified perspective of the roles of NO 
in the regulation of endothelial function and microvessel permeability.  
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Caveolin-1, the primary coating protein of caveolae, has been recognized as a key 
regulator of eNOS activation through binding of its "scaffolding domain".  In Chapter 2, by 
using a chimeric peptide with a cellular internalization sequence (homeodomain of 
antennapedia (AP) fused to the caveolin-1 scaffolding domain (amino acids 82−101), 
which we named as AP-CAV, we were able to specifically inhibit eNOS and its basal NO 
production. Our results suggested that the reduced basal NO did not directly increase 
microvessel permeability. It is consistent with results from eNOS knockout mice that basal 
permeability is not affected by the absence of eNOS.36 
NO and leukocyte adhesion 
Before we discuss the role of NO in leukocyte adhesion, it is important to briefly review 
the process of the recruitment of leukocytes into inflamed tissues. The adhesion of 
leukocytes to vascular endothelium is one of the most dramatic cellular responses of the 
inflammatory process. The recruitment process has been intensively investigated and 
characterized into several main steps. This recruitment process requires specific adhesion 
glycoproteins in the interaction of leukocytes with ECs. Initially, leukocytes marginate to the 
vascular wall due to both physical and chemical factors, such as piled up red blood cells 
behind leukocytes and the secretion of chemokines.37, 38 Then the leukocytes start to roll 
and tether in a process involving a group of selectin family proteins,  such as L-selectin at 
the surface of leukocytes, and E-selectin and P-selectin expressed on activated ECs. 39 
After cytokines activate both leukocytes and endothelium, leukocytes get into a stationary 
state in which the leukocyte remains firmly attached to the endothelial cell surface, without 
rotational motion. This is mediated by the CD11/CD18 on the leukocytes and ICAM-1 or 
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VCAM-1 on the ECs.19 Following the firm adhesion, leukocytes may transmigrate from 
postcapillary venules into the interstitial space through a paracellular or transcellular route, 
a process involves PECAM-1 and ICAM-1.38 
Studies performed in various in vitro or animal models have shown the role of NO in 
anti-leukocyte adhesion. This was supported by the facts that non-specific NOS inhibitors, 
such as NG-Monomethyl-L-arginine (L-NMMA) or NG-nitro-L-arginine methyl ester (L-
NAME), evoked marked increases in the attachment of leukocytes to endothelial cells. 9, 40-
42. Also, it has been shown that NO donors (nitroprusside, SIN-I) and superoxide dismutase 
attenuate or prevent the leukocyte adherence induced by different inflammatory stimuli.43 
Although it is well known that leukocyte-endothelial interaction is dependent on the 
expression or activity of adhesion molecules, the role of NO in regulating those molecules 
has not been fully elucidated. In vivo studies on cats and rats suggested that giving L-
NMMA or L-NAME systemically causes the increase of CD11/CD18 complex expression 
on leukocytes 9, 41, 44. It was also shown that superfusion of the rat mesentery with L-NAME 
significantly increased leukocyte rolling and adherence in mesenteric venules through 
enhanced the expression of P-selectin.45 In addition, in vitro studies indicated that the anti-
adhesive role of NO could also be attributed by changing the expression or activity of ICAM-
1 and VCAM-1.46, 47 However, those observations are not consistent with each other due 
to different animal species, tissue origins and experimental preparations.  
In Chapter 2, we found that perfusion of AP-CAV in rat postcapillary venules, not only 
inhibited the basal NO production, it also increased adhesive binding sites of ICAM-1 for 
leukocyte adhesion. Moreover, we showed significant increases in phospho-(Y526)-ICAM-
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1 staining following AP-CAV perfusion, which was abolished by a Src kinase inhibitor, PP1. 
Consistent with our findings, overexpression of caveolin-1 was shown to reduce NO 
production in vitro 48-50, and eNOS-deficient mice showed an increased number of adherent 
leukocytes. 51 These results demonstrated that the reduced basal NO does not directly 
increase permeability, but rather primes the microvascular endothelial cells into an 
adhesive state.  
SHEAR STRESS AND MICROVESSEL PERMEABILITY 
Blood flow-generated hemodynamic forces are the most physiologically relevant factors 
for the maintenance and regulation of the homeostasis of endothelial cells. Hemodynamic 
forces can be divided into two major vectors which are tensile stress (pressure) and SS. 
The stress perpendicular to the vessel wall is defined as tensile stress, which imposes 
circumferential stretch to the tissue. The stress parallel to the vessel wall is defined as SS, 
which serves as frictional force acting on the surface of endothelial cells. There has been 
substantial evidence that early atherosclerotic plaques develop mainly in regions of low wall 
SS, such as arterial bifurcations, whereas vascular regions with high laminar wall SS are 
less prone to develop atherosclerotic plaques.11, 52 Disrupted endothelial function, including 
vascular barrier dysfunction, have been considered as the major causes of 
atherosclerosis.3, 53 Thus, it is essential to study how SS regulates the endothelial cell 
signaling and related vascular barrier function.  
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Shear stress and NO production 
Although there is a large body of studies trying to elucidate how SS induce EC to 
generate NO, the knowledge of SS-induced NO production still remains unclear. Firstly, 
due to low concentration and short half-life of NO, it is difficult to accurately measure it in 
real time. In addition, it is particularly challenging in detecting NO produced in response to 
shear stress due to changes in flow caused other changes such as chemical degradation. 
Several direct and indirect techniques have been established to measure NO. Indirect 
methods involve measurement of nitrite or nitrate (the end product of NO metabolism) using 
the Griess reagent, 54 detecting soluble guanylyl cyclase (sGC) (which is activated after NO 
binding) using chemiluminescence methods, 55 and  measurement of cGMP, which is 
produced by activated sGC, using a sGC derived fluorescence indicator. 56 Direct 
measurement of NO includes electrodes and 4’,5’-diaminofluorescein diacetate (DAF-2 
DA), a cell permeable fluorescent probe. Up to now, electrodes remain the dominant 
method for direct NO measurement. However, since NO has a sharply decreased gradient 
in concentration away from the source of production, the precise and reproducible 
positioning of the electrode becomes a critical limiting factor in this method. In Chapter 3, 
we used DAF-2 as a NO indicator to directly measure the NO production induced by flow 
shear stress. The drawback of this dye is its relative short maintaining time (about 1 to 1.5 
hrs) inside the cells in vivo. Secondly, prior in vitro studies on the role of Ca2+ in shear 
stress-mediated NO production have yielded conflicting results. Some studies suggested 
that the increase in NO production was independent of extracellular Ca2+, suggesting the 
release of Ca2+ from intracellular stores as an important source responsible for the 
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increased EC [Ca2+]i.57, 58,59 However, other studies suggested that removal of extracellular 
Ca2+ blocked flow-induced NO release from intact vessels and from cultured endothelial 
cells. 60 Also, for those cells grown on collagen-coated microcarrier beads, either removal 
of medium Ca2+ by using EGTA or chelation of intracellular Ca2+ by adding BAPTA did not 
block flow-mediated NO release. 61 Those varied results may be due to the difference in 
cultured cell origins, variable concentrations of ATP in culture media, and different 
conditions of flow (laminar or turbulence flow). Our results demonstrated that the changes 
of wall SS generated by perfusion of microvessels with either blood or plasma, induced NO 
production in vivo. Additionally, only blood perfusion induced transient increase in EC 
[Ca2+]i, suggesting that wall shear stress induced NO production may be calcium 
independent.  
Shear stress and EC [Ca2+]i changes 
Ca2+ is a major internal cell signaling component. It mediates a large range of cell 
functions such as cytoskeleton reorganization, apoptosis and contraction. A number of 
studies from different research groups have demonstrated a link between pro-inflammatory 
mediator-induced Ca2+ signaling and endothelial permeability.62-65 It has been shown that 
inhibition of Ca2+ influx and depletion of the extracellular Ca2+ abolished or significantly 
attenuated the inflammatory stimuli-induced increase in microvessel permeability. 62, 65 
These results indicate that the increase in EC [Ca2+]i is an essential signal for inflammatory 
mediator-induced increases in microvessel permeability. It is proposed that blood flow-
generated SS modulates endothelial calcium response via two pathways under 
physiological condition.66 Firstly, SS enhances the transfer of blood-borne agonists, e.g. 
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those inflammatory stimuli, to the endothelial cell surface, which mediates the increase of 
EC [Ca2+]i . Secondly, the permeability of the cell membrane to extracellular calcium 
increases upon pure exposure to SS. The increase of EC [Ca2+]i induced by the change in 
SS was thought to be mainly due to the influx of extracellular Ca2+ across the cell 
membrane, which is elicited by the disappearance of Ca2+ response to SS after the removal 
of extracellular Ca2+. 67 However, it has been controversial for decades whether exposure 
of EC to flow itself is accompanied by elevated cytoplasmic calcium concentration.57, 68, 69 
In those studies, the acute change of SS induced varied magnitude of increase in [Ca2+]i, 
and the effects were not related to the magnitude of the SS.68, 69 One of the main differences 
for the inconsistent observations in those studies is the amount of ATP in culture cell 
medium.69, 70 It has been shown that in the absence or a low concentration of ATP, the 
change of EC [Ca2+]i in response to the change of SS is not significant or weak.67, 69, 71 In 
Chapter 3, we showed that only blood flow-generated sudden changes in SS, but not 
plasma or similar viscous dextran-albumin-ringer fluid perfusion, induced a transient EC 
[Ca2+]i increase in a shear-magnitude-dependent manner. More interestingly, the shear-
induced ATP release from red blood cells contributes to the transient mobilization of EC 
[Ca2+]i.   
Shear-dependent permeability examined in vitro 
The development of different types of flow devices and successful lining of cultured 
endothelial monolayers on the test surfaces enables the investigation of the relationships 
between SS and the endothelial function in vitro. Up to now, there are four types of flow 
devices used to define SS: 1) parallel-disk viscometer; 2) the cone and plate viscometer; 
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3) parallel plate flow chamber; and 4) microfluidic device. Easy access to the cells and 
ready manipulation of the flow characteristics provided a great amount of information in 
understanding how cell response to the SS from changes in gene expression, cell signaling, 
to cell morphology and function.  It has been shown on Bovine Aortic Endothelial Cells 
(BAEC) and Human Umbilical Vein Endothelial Cells (HUVEC) monolayers that flow SS 
can increase Lp and electrical impedance mediated by NO. 72-75 Meanwhile, those two 
types of cells have different magnitude and duration of permeability increase in response 
to SS. The diverse responses to SS in different cell types may due to their difference in 
intracellular signaling pathways and transport properties.76 Although in vitro studies provide 
us valuable insights into potential mechanisms involved in the regulation of SS-mediated 
changes in endothelial permeability, whether it can reflect the truth in vivo is still a question. 
In fact, there are several significant differences between the cultured cell and in vivo 
situation. Firstly, most of the in vitro studies were conducted with cells grown under static 
conditions, and then exposed to SS during measurements. Thus, the observed response 
has been doubted as the adaptation to a changed SS environment rather than a direct 
effect of fluid SS on endothelium functions. Secondly, cultured cells have a proinflammatory 
phenotype. Its basal permeability is ~10 fold higher than that in intact venules.77  Thirdly, 
most in vitro studies did not include blood cells components in generating SS, which differs 
from the in vivo situation where SS is generated by blood flow.  
Shear-dependent permeability examined in vivo 
Post-capillary venules are the main sites where the permeability increase and 
recruitment of leukocytes occur during inflammation. Acute responses to changes in shear 
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stress have its physiological significance in monitoring changes in activity level or the 
demands to a specific organ on a minute-to-minute basis.78 Kajimura and Michel showed 
a positive correlation between flow velocity and potassium ion permeability in rats venules. 
79 Also, Montermini et al. demonstrated sodium fluorescein permeability increases linearly 
to flow velocity in both rat and frog venules. 78 However, although there were a few in vivo 
studies which investigated whether the shear stress (by increasing either perfusion 
pressure or shear rate) affect microvessel Lp in frog or rat mesentery venules, the clear 
pictures regarding how shear regulates the microvessel barrier function still remain 
controversial. 80-82 By using a double cannulation method, Neal and Bates could not find a 
positive correlation between increased flow rate and Lp in microvessels of frog 
mesentery.80 Using modified Landis technique, Adamson et al. did not observe a correlation 
between shear stress and Lp in vessels perfused in the orthograde direction.82 Conversely, 
using the same technique, Williams showed a dramatic increase in Lp in response to a step 
change in shear stress in rat venules.83 In addition, Kim et al. observed that changes in Lp 
were positively correlated with the magnitude of acute changes in shear stress in 
autoperfused microvessels.84  The controversy of those studies may due to the differences 
in methods, (e.g. single or double cannulation, and autoperfusion), as well as the difference 
in the nature of the perfusate (e.g. in the presence or absence of blood cells). In this study, 
we investigated the precise role of blood or non-blood flow-generated acute increase of 
wall shear stress on endothelial cell signaling and microvessel permeability. 
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Impaired glycocalyx (shear stress mechanosensor) in disease model 
Although a vast number of studies have been undertaken to investigate the 
mechanisms of shear stress-mediated mechanotransduction, the mechanosensor and 
sensing signaling, which recognizes shear stress and passes the mechanical force into 
intracellular signaling pathway have not been identified. So far, there are several 
mechanosensor candidates have been proposed on the surface of EC, such as ion 
channels,85 G-protein-coupled receptors (GPCRs), 86 caveolae, 87 adhesion proteins,88 and 
the glycocalyx.89  
The glycocalyx is an organized negatively charged mesh of glycoproteins, 
proteoglycans, glycosaminoglycans (GAGs), and associated plasma proteins of 
proteoglycans covering the endothelium. Involvement of the glycocalyx in EC responses to 
shear stress has been demonstrated by enzymatic removal Heparan Sulfate using 
heparinase III on BAEC completely inhibited NO production induced by fluid shear stress. 
90 However, the glycocalyx in cultured cells is considerably thinner than that in intact 
venules.91 Therefore, it is important to investigate the roles of the glycocalyx in shear stress-
mediated endothelium functions in intact microvessels. 
Besides its function as a mechanosensor, glycocalyx serves throughout the vasculature 
as an aegis, protecting blood vessels from coagulation, inflammation and atherosclerosis. 
Decreased glycocalyx volume has been reported in diabetic patients.14 A study in frog 
microvessels showed an increased  microvessel hydraulic conductivity (Lp) upon partial 
digestion of the endothelial glycocalyx.92 Our previous study found an increased basal 
permeability and enhanced permeability responses to inflammatory mediators in venules 
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of streptozotocin-induced diabetic diabetic rats.93 Whether the increased permeability in 
diabetic rats is a result of an impaired glycocalyx remains unknown. In Chapter 4, we 
conducted experiments to test the hypothesis that hyperglycemia-induced damages to the 
glycocalyx contribute to the increases in microvessel permeability in diabetic rats. Also, we 
investigated the effect of impaired glycocalyx on changes in shear stress-induced nitric 
oxide (NO) production in individually perfused venules of diabetic rats. 
ENDOTHELIALIZED MICROFLUDIC DEVICE – MINIATURIZED FUNCTIONAL 
MICROVESSELS  
The idea of using microfluidic devices as miniaturized whole organ or tissue is much the 
same way as a microelectronic circuit is an entire computer on a chip. Since the idea came 
out, microfluidic technology has given great promise to overcome the challenge of 
performing in vitro experiments with more physiologically realistic setups but still easier and 
cheaper to handling than animal studies. In Chapter 5, in vitro growth microvessel network 
using the microfluidic approach and characterized the ECs’ junction, responses to shear 
stresses, NO production, and endothelial [Ca2+]i. The results demonstrated that the model 
successfully recapitulates key aspects and functions of the in vivo microvessels.  
 
 
 
 
 
 
 
 
 
 
  
 
 
20 
 
 
 
 
OBJECTIVES 
 
Specific Aim 1 to investigate the roles of exogenously applied CAV in endothelial basal 
NO production, leukocyte adhesion, and adhesion-induced changes in microvessel 
permeability. 
 
Specific Aim 2 is to investigate the cellular and molecular mechanisms for how shear 
stress regulates microvessel functions under physiological conditions.  
 
Specific Aim 3 is to investigate the role of impaired glycocalyx in microvessel barrier 
dysfunction in diabetes.  
 
Specific Aim 4 is to demonstrate in vitro formation of microvessels that recapitulate key 
features of the microvessels in vivo. 
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ABSTRACT  
Exogenously applied caveolin-1 scaffolding domain (CAV) has been shown to inhibit 
inflammatory mediator-induced nitric oxide (NO) production and NO-mediated increases in 
microvessel permeability. However, the effect of CAV on endothelial basal NO that 
prevents leukocyte adhesion remains unknown. This study aims to investigate the roles of 
exogenously applied CAV in endothelial basal NO production, leukocyte adhesion, and 
adhesion-induced changes in microvessel permeability. Experiments were conducted in 
individually perfused rat mesenteric venules. Microvessel permeability was determined by 
measuring hydraulic conductivity (Lp). NO was quantified with fluorescence imaging in 
DAF-2-loaded vessels. Perfusing venules with CAV inhibited basal NO production without 
affecting basal Lp. Resuming blood flow in CAV perfused vessels significantly increased 
leukocyte adhesion. The firmly adherent leukocytes altered neither basal Lp, nor adherens 
junction integrity. Increases in Lp occurred only upon formyl-Met-Leu-Phe application that 
induces release of reactive oxygen species from the adherent leukocytes. The application 
of NO synthase inhibitor showed similar results to CAV, and NO donor abolished CAV-
mediated leukocyte adhesion. Immunofluorescence staining showed increases in binding 
of ICAM-1 to an adhesion-blocking antibody concurrent with a Src-dependent ICAM-1 
phosphorylation following CAV perfusion. Pre-perfusing vessels with anti-ICAM-1 blocking 
antibody or a Src kinase inhibitor attenuated CAV-induced leukocyte adhesion. These 
results indicate that the application of CAV, in addition to preventing excessive NO-
mediated permeability increases, also causes reduction of basal NO and promotes ICAM-
1-mediated leukocyte adhesion through Src activation-mediated ICAM-1 phosphorylation. 
CAV-induced leukocyte adhesion was uncoupled from leukocyte oxidative burst and 
microvessel barrier function, unless in the presence of a secondary stimulation. 
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INTRODUCTION 
Nitric oxide (NO), in addition to being a potent vasodilator, has also been considered a 
“double edged sword”-mediator in inflammation. Excessive NO production induced by 
inflammatory mediators contributes to an increase in microvessel permeability and plays a 
pro-inflammatory role. 1-3 Constitutive (or basal) NO production, on the other hand, has 
been reported to prevent leukocyte adhesion and platelet aggregation on the vessel wall, 
therefore, playing an anti-inflammatory role. 4-6  
Caveolin-1, the major structural protein in the caveolae of endothelial cells, is a 
recognized endogenous inhibitor of endothelial nitric oxide synthase (eNOS). 7, 8 The 
discovery of the scaffolding domain of caveolin-1 (CAV) that directly interacts with eNOS, 
and the use of Antennapedia homeodomain (AP) fusions to facilitate CAV uptake by living 
cells, provided a valuable tool for investigating the mechanisms involved in the regulation 
of eNOS activity through protein-protein interaction and NO-dependent vascular functions 
in vivo. Our previous studies demonstrated that exogenously applying AP-CAV to a 
perfused intact microvessel inhibits platelet activating factor (PAF)-induced NO production 
and NO-mediated increases in microvessel permeability. 9, 10 In whole animal studies, the 
administration of AP-CAV suppressed tissue edema and vascular leakage. 11 These 
studies suggest an anti-inflammatory therapeutic potential for AP-CAV. However, whether 
the exogenously applied caveolin-1 peptide affects basal endothelial NO production has 
not been studied. If AP-CAV inhibits basal NO, whether it causes leukocyte adhesion and 
increases microvessel permeability is unknown. This study directly addresses these 
  
 
 
34 
 
questions by measuring basal NO, microvessel permeability, and leukocyte adhesion in 
AP-CAV-perfused intact microvessels.  
Experiments were conducted in individually perfused venular microvessels in rat 
mesenteries. We first quantitatively measured the effect of AP-CAV on endothelial basal 
NO production with DAF-2 using fluorescence imaging. We then examined the effect of 
AP-CAV on leukocyte adhesion, the mechanisms involved in the increases in adhesive 
activity of endothelial cells, and their impact on microvessel permeability. Permeability was 
determined by measuring hydraulic conductivity (Lp). The changes in endothelial junction 
integrity and adhesive capacity of adhesion molecules were evaluated by confocal imaging 
of immunofluorescence staining on AP-CAV-perfused microvessels.  
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METHODS 
Animal preparation 
Experiments were carried out on venular microvessels in rat mesenteries. All procedures 
and animal use were approved by the Animal Care and Use Committee at West Virginia 
University. Female Sprague-Dawley rats (2–3-mo old; body wt 220–250 g; Hilltop Laboratory 
Animals; Scottdale, PA) were anesthetized with pentobarbital sodium given subcutaneously. 
The initial dosage was 65 mg/kg of body weight with an additional 3 mg dose given as 
needed. The trachea was intubated, and a midline surgical incision (1.5–2 cm) was made in 
the abdominal wall. The mesentery was gently moved out of the abdominal cavity and spread 
over a glass cover slip attached to an animal tray. The upper surface of the mesentery was 
continuously superfused with mammalian Ringer solution. The temperature of the 
superfusate was maintained at 37°C. All experiments were carried out on venular 
microvessels with diameters ranging between 40 and 50 μm. Each experiment was 
performed on a single microvessel with one experiment per animal. 
Measurement of Lp in individually perfused rat mesenteric microvessels  
Modified Landis technique was used to measure the volume flux of water across the 
microvessel wall. The methods have been evaluated in detail. 12, 13 In brief, a single 
microvessel was cannulated with a micropipette and perfused with albumin-Ringer solution 
(control) containing 1% (vol/vol) hamster red blood cells as markers. A hydrostatic pressure 
(range 40–60 cmH2O) was applied through the micropipette to the microvessel lumen to 
maintain a continuous flow. Water flux was measured when the vessel was briefly occluded 
downstream. Lp was calculated as the slope of the relationship between the initial water flux 
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per unit area of microvessel wall and the pressure difference across the microvessel wall. In 
each experiment, the baseline Lp and the Lp after application of testing solutions were 
measured in the same vessel and the changes in Lp were expressed as the ratio of Lptest / 
Lpcontrol 
Fluorescence imaging of endothelial nitric oxide production   
Endothelial NO production was measured on DAF-2 DA loaded vessels using 
fluorescence imaging. Experiments were performed on a Nikon Diaphod 300 microscope 
equipped with a 12-bit digital CCD camera (ORCA; Hamamatsu) and a computer controlled 
shutter (Lambda 10-2; Sutter Instrument; Novato, CA). A 75-W xenon lamp was used as 
the light source. The excitation wavelength for DAF-2 was selected by an interference filter 
(480/40 nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass 
barrier (535/50 nM). All the images were acquired and analyzed using Metafluor software 
(Universal Imaging). To minimize the photo-bleaching, a neutral density filter (0.5 ND) was 
positioned in front of the interference filter and the exposure time was minimized to 0.12 
sec at 1 min intervals.  
During the experiments, each vessel was cannulated and perfused with albumin-Ringer 
solution containing DAF-2 DA (5 µM) throughout the experimental duration. Image 
collection was started at the beginning of DAF-2 DA perfusion. All images were collected 
from a group of endothelial cells located in the same focal plane of the vessel wall using a 
Nikon Fluor lens (x20, numerical aperture, 0.75). A steady-state of endothelial DAF-2 
fluorescence (FIDAF) with continuous perfusion of DAF-2 DA was indicated by the rate 
change of the increased FI. Quantitative analysis was conducted at the individual 
  
 
 
37 
 
endothelial cell level using selected regions of interest (ROIs) along the vessel wall. Each 
ROI covers the area of one individual cell as indicated by the fluorescence outline. The 
tissue autofluorescence was subtracted from all of the measured FIs. The basal NO 
production rate was calculated from the slope of the FIDAF increase during albumin-Ringer 
perfusion after DAF-2 loading reached the steady-state. FIDAF was expressed in arbitrary 
units (AU). The rate of FIDAF increase (df /dt) derived by first differential conversion of 
cumulative FIDAF over time indicates the rate of NO production. Details have been 
described. 14 
Immunofluorescence staining and confocal imaging 
     VE-cadherin and adherent leukocyte staining was conducted in vessels after CAV-
induced leukocyte adhesion. Phosphorylated ICAM-1 at Y526 staining was conducted in 
vessels after 30 min AP-CAV perfusion in the presence or absence of the Src kinase 
inhibitor, PP1. The rat mesentery bearing the perfused vessel was fixed with 1% 
paraformaldehyde and treated with triton X-100 before exposure to primary antibodies 
against VE-cadherin (C-19, sc-6458, Santa Cruz Biotechnology) and CD45 (clone OX-1, 
Biolegend), or phospho-(Y526)-ICAM-1 (ab51033, Abcam) and followed by incubation with 
their corresponding secondary antibodies (Invitrogen).  
ICAM-1 staining was conducted in intact microvessels. Each venule was first perfused 
with albumin-Ringer solution for 10 min and then perfused with ICAM-1 primary antibodies 
(1A29 BD Pharmingen, 0.1 mg/ml) for 20 min. The secondary antibody (Invitrogen) was 
applied to each vessel for 15 min after washout of the primary antibody from the vessel 
lumen. Nuclei were labeled by perfusion vessels with DRAQ5 (Biostatus). The confocal 
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images were acquired after all of the fluorescence markers were washed out from the 
vessel lumen.  
     All of the images were acquired using Leica confocal microscope. Each image stack 
was collected by optical sectioning at successive X-Y focal planes with a vertical depth of 
0.3 µm (phospho-(Y526)-ICAM-1) and 0.5 µm (ICAM-1) using Leica X25 objective (HC 
Plan APO, NA 0.95) and 1024 x 1024 scanning format. Leica software was used for image 
acquisition and image analysis. 
The fluorescence intensity (FI) of labeled ICAM-1 and phospho-(Y526)-ICAM-1 was 
quantified from a segment of the vessel wall. The total FI was calculated as area × depth × 
mean amplitude, where the area is the selected ROI per vessel section and the depth is 
the total number of images at z dimension. Because ICAM-1 was expressed on endothelial 
cell surface, FI was quantified as total intensity per square micrometer of vessel wall (FI/A). 
Assuming a cylindrical geometry, surface area of the vessel wall was calculated as 2π × r 
× L, where r is the radius of the microvessel and L is the length of selected ROI from the 
vessel.  
Solutions and reagents  
Mammalian Ringer solution 15 was used for the experiments. All perfusates contained 
albumin-Ringer solution (BSA, 10 mg/ml). AP-CAV, the fusion peptide of caveolin-1 
scaffolding domain with AP, the Antennapedia internalization sequence from Drosophila 
Antennapedia homeodomain, and AP-CAV-X, the fusion peptide of scrambled CAV with 
AP were synthesized by Tufts University. 11 The chemotactic peptide formyl-Met-Leu-Phe-
OH (fMLP) was purchased from Calbiochem (San Diego, CA). PP1 (4-amino-5-(4-
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methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine), sodium nitroprusside and N(omega)-
monomethyl-l-arginine (L-NMMA) were purchased from Sigma (St. Louis, MO). The stock 
solutions were prepared with 100% DMSO and each final solution was achieved by 
>1:1,000 dilution with albumin-Ringer solution.  
Data analysis and statistics   
All values are mean ± SE. Paired t-test was used for paired data analysis. ANOVA was 
used to compare data between groups. A probability value of P < 0.05 was considered 
statistically significant.  
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RESULTS 
AP-CAV inhibits basal NO production without affecting basal Lp in intact venules 
The effect of AP-CAV on basal NO was examined in four vessels. A steady-state of DAF-
2 fluorescence intensity, FIDAF, was reached at 39.5 ± 1.3 min with continuous DAF-2 DA 
perfusion. The FIDAF accumulation rate, an indication of basal NO production rate, was 0.13 
± 0.01 AU per min. After perfusion of each vessel with AP-CAV (10 µM), FIDAF accumulation 
rate significantly decreased to 0.02 ± 0.01 AU per min within 1 min (P < 0.01). To confirm 
that DAF-2 was still functional after the application of AP-CAV, a NO donor, SNP (10 µM) 
was added to the perfusate in the presence of AP-CAV in two of the vessels. The FIDAF 
increased at a relatively linear rate of 0.15 ± 0.01 AU per min, which is comparable with 
that under control conditions (Fig. 1A and 1C). Based on these results we estimate that the 
level of NO generated by 10 µM SNP is close to basal NO production rate. To compare the 
inhibitory effect of AP-CAV on basal NO with that of the NOS inhibitor, basal NO production 
was measured in another eight vessels in the absence or presence of L-NMMA (500 µM, 
four vessels per group). The mean FIDAF accumulation rate of four vessels was 0.13 ± 0.02 
AU per min and was significantly decreased to 0.01 ± 0.002 AU per min in the presence of 
L-NMMA (Fig. 1B and 1C), demonstrating a similar magnitude of basal NO reduction to 
that of AP-CAV.   
To examine whether reduced basal NO via perfusion of AP-CAV has a direct effect on 
basal permeability, we measured Lp in four microvessels. The mean baseline Lp of the four 
vessels was 1.8 ± 0.2×10-7 cm·s-1·cmH2O-1. After perfusing vessels with AP-CAV (10 μM) 
for 30 min, the mean Lp was 1.8 ± 0.3 ×10-7 cm·s-1·cmH2O-1, not significantly different from 
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that of the control.  Fig. 2 shows a single experiment and the data summary. Our previous 
study demonstrated that perfusion of mesenteric venules with AP-CAV at 1 µM for 30 min 
also did not affect basal Lp. 9  
AP-CAV perfusion induces leukocyte adhesion without increasing microvessel 
permeability unless in the presence of a secondary stimulation.  
The effect of AP-CAV-induced basal NO reduction on leukocyte adhesion was 
examined in 8 microvessels. Each vessel was perfused with 1 or 10 μM of AP-CAV for 30 
min followed by resuming blood flow in the perfused microvessel for 10 min. When each 
vessel was re-cannulated with albumin-Ringer perfusate, we observed a dose-dependent 
leukocyte adhesion. In vessels perfused with AP-CAV at 1 μM, the adherent leukocytes 
increased from baseline levels of 0.7 ± 0.1 to 8.4 ± 0.1 per 100 μm of vessel length (n = 3, 
p < 0.05).  In 10 μM AP-CAV-perfused vessels, the mean adherent leukocytes increased 
from baseline levels of 1.3 ± 0.2 to 26.3 ± 3.2 per 100 μm of vessel length (n = 5). The left 
panel of Fig. 3A demonstrates the representative images of leukocyte adhesion before and 
after AP-CAV (10 μM) perfusion followed by resumed blood flow from a single vessel. When 
Lp was measured in the presence of CAV-induced adherent leukocytes, the mean value 
was 2.1 ± 0.1 × 10-7cm·s-1·cmH2O-1, which was not significantly different from the mean 
baseline Lp, 1.7 ± 0.2 ×10-7 cm·s-1·cmH2O-1.  
Our previous study showed that formyl-Met-Leu-Phe (fMLP) can stimulate reactive 
oxygen species (ROS) release from TNF-α-induced adherent leukocytes, resulting in 
increases in microvessel Lp. 16 Here, we further investigated whether exposing CAV-
induced adherent leukocytes to fMLP increases Lp. We added fMLP (10 μM) to the 
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perfusate after leukocyte adhesion in AP-CAV perfused vessels. To maximize the local 
concentration of ROS released from the adherent leukocytes upon fMLP stimulation, the 
perfusate was kept at a balanced pressure (no flow) for 5 min before Lp measurement. Lp 
measured after 5 min stationary flow transiently increased to mean peak values of 4.8 ± 
0.6 and 16.3 ± 2.1 times that of the control in 1 and 10 μM AP-CAV perfused vessels, 
respectively. The 5 min stationary flow in the absence of adherent leukocytes does not 
affect Lp. 16 Fig 3B shows a typical time course of the Lp changes in a single experiment. 
Fig. 3C shows result summary (2 panels on the left). 
Nitric oxide donor prevents AP-CAV induced leukocyte adhesion  
To examine whether the AP-CAV-induced reduction of basal NO is responsible for 
increased leukocyte adhesion, we applied a NO donor, SNP, during AP-CAV perfusion in 
four vessels. The mean baseline Lp was 1.7 ± 0.1 ×10-7 cm·s-1·cmH2O-1. Each vessel was 
first perfused with AP-CAV (10 μM) and SNP (10 μM) for 30 min, followed by 10 min of 
resumed blood flow with superfusate containing SNP (20 μM). When each vessel was 
recannulated with albumin-Ringer perfusate, the mean number of adherent leukocytes was 
only 3.7 ± 1.1 per 100 μm of vessel length, which was a significant reduction from AP-CAV 
perfusion alone and not significantly different from that of the baseline. The right panel of 
Fig. 3A demonstrates the representative images before and after AP-CAV and SNP 
perfusion followed by resumed blood flow from one single vessel. We also measured Lp 
when vessels were perfused with SNP and AP-CAV, which showed no significant 
difference from that of the control (Fig. 3C, 3rd panel from left).  
Scrambled AP-CAV peptide does not affect leukocyte adhesion and microvessel Lp 
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AP-CAV-X (10 µM) was used to examine the specificity of AP-CAV in another three 
microvessels. Experiments were conducted under identical conditions to that of AP-CAV 
application. No significant leukocyte adhesion or changes in Lp were observed after 
resuming blood flow in AP-CAV-X perfused vessels. The mean number of adherent 
leukocytes before and after resuming blood flow was 0.8 ± 0.1 and 1.1 ± 0.2 / 100 μm of 
vessel length, and the mean Lp measured under each condition was 1.7 ± 0.2 and 1.8 ± 
0.2 ×-7 cm·s-1·cmH2O-1, respectively (Fig. 3C, far right panel).  
Inhibition of NOS by L-NMMA shows similar results to the application of AP-CAV  
If AP-CAV-induced leukocyte adhesion is attributed to its inhibitory effect on basal NO, 
we would expect the similar effect from the application of NG-Methyl-L-arginine (L-NMMA), 
a NOS inhibitor. Experiments were conducted in three microvessels. Fig. 4A shows a 
representative time course of the Lp changes in a single experiment.  The mean control Lp 
of three vessels was 2.4 ± 0.3×10-7 cm·s-1·cmH2O-1. After application of L-NMMA to both 
perfusate (100 µM) and superfusate (500 µM) for 30 minutes followed by 20 minutes 
resumed blood flow, the mean adherent leukocytes to the microvessel wall increased from 
a mean baseline level of 0.8 ± 0.2 to 14.8 ± 2.5 per 100 µm of vessel length.  Consistent 
with the results of AP-CAV-induced leukocyte adhesion, Lp measured in the presence of 
L-NMMA-induced adherent leukocytes was 2.7 ± 0.6 ×10-7 cm·s-1·cmH2O-1, not significantly 
different from its control. When fMLP was applied to the perfusate, Lp measured after 5 
min of stationary flow transiently increased to a mean peak value of 5.4 ± 0.9 times that of 
the control. Fig. 4B summarizes the results. 
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AP-CAV-induced leukocyte adhesion does not change endothelial adherens 
junction 
Our results showed that AP-CAV-induced leukocyte adhesion did not change basal Lp. 
We then further examined the location of adherent leukocytes and whether the adherent 
leukocytes cause local structural changes of endothelial junctions. Immunofluorescence 
staining was used to simultaneously label adherent leukocytes and VE-cadherin in three 
vessels. The representative confocal images shown in Fig. 5 illustrate that AP-CAV-
induced leukocyte adhesion did not change the distributions of VE-cadherin at endothelial 
junctions. Endothelial junctions were outlined by continuous VE-cadherin that had no 
apparent interruptions, even underneath the site of the attached leukocyte. In addition, the 
dual staining of both leukocyte and VE-cadherin demonstrated that the majority of adherent 
leukocytes selectively adhered at or near endothelial junctions.  
Reduced basal NO by AP-CAV increases the adhesive capacity of ICAM-1 on the 
surface of endothelium lining microvessel walls.  
Our results showed that leukocytes were firmly attached to the venular walls after 
resuming blood flow in vessels that has been exposed to AP-CAV. We then investigated 
whether AP-CAV-induced NO reduction affects the adhesive capacity of intercellular 
adhesion molecule-1 (ICAM-1), an important molecule mediating the firm adhesion of 
leukocytes to the vascular endothelium. A monoclonal blocking antibody directed against 
ICAM-1 (mAb1A29) 17, 18 was used to evaluate the changes in adhesive activity of ICAM-1 
on endothelial cells lining the venular walls after 30 min perfusion of AP-CAV.  AP-CAV 
perfusion at 1 and 10 µM significantly increased the mean FI of mAb1A29 to 2.4 ± 0.2 and 
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9.5 ± 1.7 times that of the control, respectively (n = 4 per group). The application of 10 µM 
SNP abolished AP-CAV-induced increases in mAb1A29 binding (n = 3), and perfusion of 
AP-CAV-X (10 µM) showed no difference in mAb1A29 binding from that of the control (n = 
3). Fig. 6 shows representative confocal images and summarized FI quantification of 
mAb1A29 staining in 5 group of studies. 
Anti-ICAM-1 blocking antibody attenuates AP-CAV-induced leukocyte adhesion  
To confirm that the specific binding of mAb1A29 to ICAM-1 are directly associated with 
the adhesive activity of ICAM-1, we perfused microvessels with mAb1A29 before and 
during AP-CAV application. The initial number of adherent leukocytes under albumin-
Ringer perfusion was 1.0 ± 0.3 per 100 μm of vessel length (n = 5). Each vessel was then 
perfused with mAb1A29 (0.1 mg/ml) for 30 minutes followed by perfusion of AP-CAV (10 
μM) in the presence of mAb1A29 for another 30 min before resuming blood flow. When 
each vessel was re-cannulated with albumin-Ringer perfusate after 10 min of blood flow, 
the mean number of adherent leukocytes was only 4.5 ± 0.8 per 100 μm of vessel length, 
which is a significant reduction from that of AP-CAV perfusion alone (26.3 ± 3.2 per 100 
μm of vessel length). Fig. 6C summarizes the results.  
ICAM-1 Phosphorylation at Tyrosine 526 is required for AP-CAV-induced leukocyte 
adhesion 
 Studies have demonstrated that TNF-α-induced early phase of leukocyte adhesion 
involves Src activation-mediated phosphorylation of ICAM-1. 19, 20 We then examined 
whether this mechanism also applies to AP-CAV-induced ICAM-1-dependent leukocyte 
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adhesion using fluorescence immunostaining and confocal imaging. We found that 30 min 
perfusion of AP-CAV (10 μM) caused a marked increase in ICAM-1 phosphorylation at 
tyrosine 526 (Y526) on endothelial cells lining the venular walls compared to that of the 
control. The same period of AP-CAV-X perfusion showed no such effect. Preferfusing 
vessels with PP1 (10 µM), a src kinase inhibitor, abolished AP-CAV-induced ICAM-1 
phosphorylation.  Representative confocal images are shown in Fig 7A and the FI 
quantifications are summarized in Fig 7B (n = 3 per group). The role of AP-CAV-induced 
ICAM-1 phosphorylation in AP-CAV-induced leukocyte adhesion was examined in another 
3 vessels.  Each vessel was first perfused with PP1 (10 μM) for 30 min before adding AP-
CAV (10 μM) for another 30 min perfusion. After 10 min of resumed blood flow, the mean 
number of adherent leukocytes was only 4.6 ± 0.1 per 100 μm of vessel length, which was 
significantly lower than that of AP-CAV perfusion alone (26.3 ± 3.2 per 100 μm of vessel 
length). Fig. 7C summarizes the results.  
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DISCUSSION 
Our study demonstrated for the first time that exogenously applied AP-CAV, in addition 
to inhibition of stimulus-induced increases in NO production and microvessel permeability, 
9, 10, 21 also reduces basal NO production in endothelial cells lining microvessel walls. Most 
importantly, this study revealed how reduced basal NO affects the adhesiveness and 
barrier function of endothelial cells in intact microvessels. While reduced basal NO by AP-
CAV did not directly change basal microvessel permeability, it increased the adhesive 
capacity of endothelial cells and promotes leukocyte adhesion via Src-mediated 
phosphorylation of ICAM-1. Our results that NO donor abolished the effect of AP-CAV on 
increased ICAM-1 binding to a blocking antibody and leukocyte adhesion support an 
important anti-adhesive role of basal NO in maintaining the homeostasis of vascular walls. 
Although the experiments focused on the effect of AP-CAV on microvessels, the identified 
cellular mechanisms may represent the microvascular manifestations associated with 
reduced basal NO under various pathological conditions in vivo.  
CAV reduces basal NO production and promotes leukocyte adhesion in intact venules 
The relationship between Caveolin-1 and eNOS is one of the fundamental discoveries 
of caveolae involvement in cardiovascular functions. Cell culture and purified protein 
binding studies demonstrated that caveolin-1 inhibits eNOS activity by a direct interaction 
with eNOS through its N-terminal “scaffolding domain,” located between amino acids 82 
and 101 within endothelial plasmalemmal caveolae. 7, 8, 22 Although the effect of the 
caveolin-1 scaffolding domain peptide on eNOS activity has been extensively studied for 
decades, most of the in vivo studies were conducted in vessels with acute exposure to 
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inflammatory mediators. 9-11, 23 We previously demonstrated that when individually perfused 
venules were exposed to PAF, the excessive NO production triggered by increased 
endothelial [Ca2+]i was a necessary signal for permeability increases, 21, 24 and that the 
application of AP-CAV, which inhibits PAF-induced NO, prevents the increases in 
microvessel permeability. 9, 10 The systemic application of AP-CAV in mice has been shown 
to suppress carrageenan and mustard oil-induced vascular leakage, as well as the 
hyperpermeability of tumor vasculature. 11, 23, 25 These in vivo evidence suggest a promising 
anti-inflammatory therapeutic potential of AP-CAV in protecting endothelial barrier function 
through its inhibitory effect on inflammation-associated eNOS activation. 9-11, 26 However, 
NO has also been known as an anti-adhesive molecule and plays anti-inflammatory roles 
in preventing platelet and leukocyte adhesion on microvessel walls. 5, 27 How the inhibitory 
action of AP-CAV on eNOS affects the anti-inflammatory roles of basal NO has not been 
previously investigated. Detecting changes in basal NO requires a sensitive method, 
because the magnitude of basal NO production is much smaller than that induced by 
inflammatory mediators. Using continuous perfusion of NO indicator, DAF-2, to measure 
basal NO is a new method recently developed in our laboratory. 14 This method enables 
the endothelial cells lining the microvessel wall to maintain a relatively constant dye 
concentration, which enhances the sensitivity of NO detection. Using this method, we 
provided direct evidence that the exogenously applied AP-CAV, in addition to its role in 
suppression of stimulus-induced increases in NO production and microvessel permeability, 
also inhibits basal NO in intact venules and promotes leukocyte adhesion. The addition of 
NO donor that reversed the CAV effect on leukocyte adhesion supports a causal 
relationship between the reduced NO and increased leukocyte adhesion. Based on these 
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findings we further investigated the mechanisms involved in increased adhesiveness of 
microvessel walls by reduced basal NO and the impact of increased adhesive activity of 
endothelium on microvessel permeability.  
Role of basal NO in the regulation of microvessel permeability 
NO has been recognized as an important endothelial factor that is not only a potent 
vasodilator regulating vascular tone and blood pressure, but is also an important intrinsic 
modulator of microvessel permeability. 4, 28-31 Despite decades of studies, the exact roles 
of NO in the regulation of microvessel permeability remain controversial. Some studies 
showed that the application of NOS inhibitors increased vascular leakages, especially in 
the presence of blood. 4, 32-34 Others showed that inhibition of NO prevented permeability 
increases in response to inflammatory mediators. 3, 9-11, 21, 23, 24, 26, 31, 35 The inconsistent 
results were usually derived from different experimental approaches, organ vasculatures, 
tissue conditions, and animal species. Our present study was conducted in intact 
microvessels under basal conditions. Combined with our previous findings on stimuli-
induced NO and microvessel permeability, 9, 10, 21, 24 we revealed dual actions of NO on 
endothelial functions using the same experimental preparation, but under different 
conditions, which provides a unified perspective of the roles of NO in the regulation of 
endothelial function and microvessel permeability. Our results demonstrated that reducing 
basal NO production by AP-CAV perfusion increased leukocyte adhesion through an 
alteration of endothelial ICAM-1 adhesive capacity on the surface of endothelial cells lining 
intact microvessel walls. Neither the increased adhesiveness of ICAM-1 alone, nor ICAM-
1-mediated leukocyte adhesion directly affect basal microvessel permeability. However, 
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the presence of chemokines can trigger a respiratory burst from adherent leukocytes, 
resulting in ROS-mediated increases in microvessel permeability (Fig 3 and 4). These 
results demonstrate that the reduced basal NO does not directly increase permeability, but 
rather primes the microvascular endothelial cells into an adhesive state. These findings 
reveal the dual roles of NO in the regulation of endothelial functions in microvessels. While 
basal NO plays anti-adhesive roles in maintaining the homeostasis of vascular walls, the 
inflammatory mediator-induced excessive NO mediates increases in microvessel 
permeability.   
The relationship between reduced basal NO, ICAM-1 expression, leukocyte adhesion, and 
microvessel permeability. 
Leukocyte adhesion to microvessel walls has been characterized as a series of 
coordinated interactions mediated by different adhesion molecules. During acute 
inflammation, the rapid recruitment of leukocytes (minutes) usually involves P-selectin 
translocation and the secretion of chemokines, 36, 37 which mediate loose interaction 
between leukocyte and endothelium, such as rolling and tethering. Firm adhesion, usually 
occurring hours after cytokine-mediated activation, is mediated by the enhanced 
expressions of VCAM-1 or ICAM-1 that requires transcription and translation of new 
proteins. 28 In contrast to this classical pattern of leukocyte/endothelium interactions, we 
observed a large number of tightly adhered leukocytes in CAV- and L-NMMA-perfused 
vessels within 10 and 20 min of resumed blood flow, respectively.  The adherent leukocytes 
were tightly attached to the microvessel walls and could not be washed away by re-
perfusing the vessel with albumin-Ringer perfusate, indicating ICAM-1-mediated adhesion. 
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Our results showed a 9.5 fold increase in ICAM-1 immunostaining in intact microvessels 
following a 30 min CAV perfusion (images in Fig 6). In this study, the anti-ICAM-1 antibody 
staining was achieved by direct perfusion of intact vessels with the antibody without fixation. 
Therefore, the observed antibody binding with ICAM-1 should only represent the levels of 
extracellular domain of ICAM-1 on the surface of endothelial cells. The timing of increased 
ICAM-1 staining could rule out the possibility of new ICAM-1 synthesis. Studies have 
demonstrated that mAb1A29 is a specific blocking antibody for ICAM-1 that inhibits ICAM-
1-mediated leukocyte adhesion. 17, 18 Our results that perfusing vessels with 1A29 
significantly inhibited AP-CAV-induced leukocyte adhesion are consistent with those 
reports. Then the increased binding affinity of ICAM-1 for this antibody upon AP-CAV 
perfusion could be the results of increased adhesive binding sites of ICAM-1 for leukocyte 
adhesion. While the evidence derived from our present study could not rule out the 
possibility of membrane translocation of ICAM-1 in response to AP-CAV-induced NO 
reduction, protein analysis from cytoplasmic and membrane fractions in cultured cells 
reported that TNF-α-induced early phase leukocyte adhesion involves the activation of 
constitutive ICAM-1 in cell surface. 19 We also explored the signaling pathways involved in 
AP-CAV-induced increases in the adhesive activity of ICAM-1. The significant increases in 
phospho-(Y526)-ICAM-1 staining following AP-CAV perfusion, not AP-CAP-X perfusion, 
showed a direct correlation between ICAM-1 phosporylation and increased endothelial 
surface ICAM-1 binding to mAb1A29. The application of a Src kinase inhibitor, PP1, that 
abolished AP-CAV-induced ICAM-1 phosphorylation and also inhibited AP-CAV-induced 
leukocyte adhesion supports that Src activation-mediated ICAM-1 phosphorylation resulted 
in increases in the adhesive activity of ICAM-1. Src activation mediated ICAM-1 
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phosphorylation that was independent of protein synthesis has also reported in TNF-α-
induced early phase leukocyte adhesion in both cell culture and mouse lung studies 19, 20. 
Our results that NOS inhibitor (L-NMMA) showed similar results to those of AP-CAV-
mediated leukocyte adhesion and that adding exogenous NO donor (SNP), or blocking 
ICAM-1, prevented AP-CAV-induced leukocyte adhesion, support that reduced basal NO-
mediated, Src activation-dependent increases in adhesive activity of ICAM-1 is the 
mechanism for AP-CAV-induced leukocyte adhesion. Most importantly, AP-CAV-induced 
increases in adhesive activity of ICAM-1 on endothelial cells appears sufficient to mediate 
firm adhesion of leukocytes within 10-20 min without the need of activating blood cells. 
Consistent with our findings, overexpression of caveolin-1 was shown to reduced NO 
production in vitro, 38-40 and eNOS-deficient mice show increased levels of leukocyte 
adhesion. 41 A rapid increase (in 30 min) in ICAM-1 expression in thrombin-stimulated 
umbilical vein endothelial cell was not inhibited by a protein biosynthesis inhibitor, 
cycloheximide. 42 However, the mechanisms involved in the anti-inflammatory roles of NO 
have been attributed to its ability to neutralize superoxide. 28, 43 It has been proposed that 
eNOS-derived NO does not directly modulate endothelial cell conversion to a pro-adhesive 
phenotype, but rather interferes with the generation of ROS by NADPH oxidase and 
prevents ROS-mediated inflammatory response. 28, 44 In contrast to this proposal, the timing 
and pattern of leukocyte adhesion observed in our studies strongly support a direct 
association between basal NO and adhesive states of endothelial cells. Although detailed 
molecular mechanisms remain to be discovered, our present studies indicate that the 
signaling pathways involved in reduced basal NO-mediated leukocyte adhesion are 
different from those induced by cytokines.  
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Our results also demonstrated that CAV-induced leukocyte adhesion, without fMLP 
stimulation, does not increase microvessel permeability. The continuous VE-cadherin 
outlined underneath the AP-CAV-induced adherent leukocytes (Fig 5) provide further 
evidence that the adhesion process did not cause local changes at endothelial adherent 
junctions, which is consistent with the permeability measurements. These findings also 
support that the process of leukocyte recruitments such as adhesion and migration may 
not necessarily cause vascular leakage. Our results that the increases in microvessel 
permeability only occurred upon the application of fMLP to vessels with AP-CAV-induced 
adherent leukocytes, further support that the adhesion process alone can be dissociated 
with increases in microvessel permeability, and the additional stimulus-induced leukocyte 
oxidative burst is the direct cause of leukocyte adhesion-mediated increases in microvessel 
permeability. 16, 45-50 This could also explain the effective anti-inflammatory actions of 
systemically applied AP-CAV without reported injury of unaffected organs by several 
investigators. 11, 23, 25, 29  
Summary 
Our experimental approach allows us to investigate microvessel functions under both 
basal and stimulated conditions, and in the absence and presence of blood components, 
thus providing us a unique opportunity to dissect the distinct roles of AP-CAV and NO in 
the regulation of endothelial function in vivo under different vascular conditions. Our present 
study on CAV-induced basal NO reduction, in combination with previous studies, 
demonstrated that basal NO is essential in maintaining the non-adhesive state of 
endothelium through regulating of endothelial surface adhesion molecules, whereas the 
stimulated excessive NO causes increases in microvessel permeability. The reduced basal 
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NO-induced increases in adhesive activity of ICAM-1 to leukocytes were mediated by Src 
activation-dependent ICAM-1 phosphorylation.  
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Figure 1. The application of Antennapedia homeodomain (AP)-caveolin-1 (CAV) 
inhibits basal nitric oxide (NO). A: the time-dependent changes in cumulative DAF-2 
fluorescence intensity (FIDAF) from one representative experiment before (○) and after (●) 
treatment with 10 μM AP-CAV, followed by 10 μM SNP (△) perfusion for 40 min. B: time-
dependent changes in cumulative FIDAF from two representative experiments in the 
absence (●) or presence of (○) of 500 μM l-NMMA. C: summary of NO production rate 
derived from cumulative FIDAF in each group of vessels. The dashed arrow indicates the 
time when DAF-2 fluorescence reached steady state. The arrow indicates the time when 
testing solution was added. †Significant decreases from control (P < 0.05). 
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Figure 2. Perfusion of AP-CAV for 30 min has no effect on basal hydraulic 
conductivity (Lp). A: a representative experiment shows the time course of Lp changes 
when the vessel was perfused with AP-CAV (10 μM). B: summary results of four 
experiments. 
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Figure 3 
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Figure 3. Reduction of basal NO by AP-CAV induced significant leukocyte adhesion 
without increasing Lp in the absence of a secondary stimulation. A: paired video 
images from two rat venules. The two images on the left show the same vessel under 
control conditions and after AP-CAV (10 μM)-induced leukocyte adhesion. The two images 
on the right show that the application of sodium nitroprusside (SNP) abolished AP-CAV-
induced leukocyte adhesion. B: the time course of Lp changes from a representative 
experiment showing that AP-CAV (10 μM)-induced leukocyte adhesion (25/100 μm of 
vessel length) did not increase Lp, unless formyl-Met-Leu-Phe-OH (fMLP) (10 μM) was 
added to the perfusate. C: summary graph showing the correlation between the number of 
adherent leukocytes (per 100 μm vessel length) and the changes in Lp in four group of 
studies. Perfusion vessels with AP-CAV at 1 μM (n = 3) and 10 μM (n = 5) show AP-CAV 
dose-dependent increases in leukocyte adhesion and fMLP-induced increases in Lp. The 
application of SNP attenuated AP-CAV-induced leukocyte adhesion (n = 4), and replacing 
AP-CAV with scrambled AP-CAV (AP-CAV-X) showed no effect on leukocyte adhesion (n 
= 3). The blank bars represent the control values. The arrows indicate the procedures of 
30 min of AP-CAV or AP-CAV-X perfusion followed by 10 min of resumed blood flow. The 
dashed line bars represent values measured after resumed blood flow in AP-CAV or AP-
CAV-X perfused vessels. *Significant increases from the control values (P < 0.05). 
†Significant decreases from AP-CAV group (P < 0.05).  
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Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 4. L-NMMA, a NO synthase (NOS) inhibitor, showed similar effects on 
leukocyte adhesion and microvessel permeability to those of CAV. A: time course of 
Lp changes from a representative experiment. B: summary of the number of adherent 
leukocytes (per 100-μm vessel length) and the corresponding changes in microvessel Lp 
(n = 3). *Significant increases from control (P < 0.05). 
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Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Confocal images of the co-staining of VE-cadherin and adherent leukocytes 
illustrating that CAV-induced leukocyte adhesion did not change VE-cadherin 
distribution. A: VE-cadherin staining under control conditions and after CAV-induced 
leukocyte adhesion. The third image shows the double staining of VE-cadherin and 
adherent leukocytes (indicated by arrows). B: magnified images from three different vessels 
showing no changes in VE-cadherin at the adhesion sites. 
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Figure 6. 
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Figure 6. AP-CAV-induced increase in ICAM-1 adhesive capacity causes leukocyte 
adhesion. A: representative confocal images of anti-ICAM-1 blocking antibody mAb1A29 
and vascular cell nuclei co-staining from five groups of studies and the secondary antibody 
control (ICAM-1 is shown in green, and nuclei are red). B: quantification of total 
fluorescence intensity (FI) of ICAM-1 per unit area of vessel wall under control conditions 
(n = 4), after AP-CAV (1 μM, n = 3; and 10 μM, n = 4) perfusion in the absence and presence 
of SNP (n = 3), and after AP-CAV-X perfusion (n = 3). C: perfusion of vessels with mAb1A29 
significantly attenuated AP-CAV (10 μM)-induced leukocyte adhesion (n = 5 per group). 
*Significant increase from control (P < 0.05). †Significant decrease from AP-CAV group (P 
< 0.05). 
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Figure 7.  
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Figure 7. AP-CAV-induced leukocyte adhesion involves Src activation-mediated 
ICAM-1 phosphorylation at tyrosine 526 (Y526). A: representative confocal images 
demonstrate increases in ICAM-1 phosphorylation at Y526 following AP-CAV perfusion 
relative to that of the control. Such increased ICAM-1 phosphorylation was blocked by the 
application of a Src kinase inhibitor, PP1, and was absent in vessels perfused with AP-
CAV-X or secondary antibody alone. Phosphorylated ICAM-1 at Y526 is shown in green, 
and nuclei are red. B: summary of changes in FI of phospho-Y526-ICAM-1 relative to 
control in each experimental group (n = 3 per group). C: perfusion of vessels with PP1 that 
prevented ICAM-1 phosphorylation also significantly attenuated AP-CAV induced 
leukocyte adhesion (n = 3). *Significant increase from control (P < 0.05). †Significant 
decrease from AP-CAV group (P < 0.05). 
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ABSTRACT  
Rationale Acute changes of shear stress (SS) have been recognized to play important 
roles in vascular dysfunctions. However, detailed mechanisms involved in SS-induced 
endothelial cell (EC) signaling and vascular barrier function in vivo have not been well 
understood, especially in the presence of red blood cells (RBCs).  
Objective This study investigates the effects of acute changes of SS on EC [Ca2+]i, eNOS 
activation, nitric oxide (NO) production, and vascular barrier function in individually perfused 
intact rat mesenteric venules. 
Methods and Results SS was quantified by measuring maximal flow velocity and fluid 
viscosity using a high-speed camera and a cone-plate viscometer. EC [Ca2+]i and NO were 
measured in Fura-2 AM and DAF-2 DA loaded venules. EC eNOS activation was evaluated 
by immunofluorescence staining with confocal imaging. ATP released from RBCs was 
measured by bioluminescence assay. In response to changes of SS, transient SS-
dependent increases in EC [Ca2+]i occurred only in vessels perfused with whole blood or 
perfusate containing RBCs, which were correlated with EC gap formation illustrated by 
fluorescent microsphere accumulation. Whereas, both plasma and whole blood perfusion 
induced SS-dependent NO production and eNOS-Ser1177 phosphorylation.  
Carbenoxolone, a Pannexin 1 inhibitor, abolished SS-dependent ATP release from RBCs 
and also prevented SS-induced increases in EC [Ca2+]i and EC gap formation. 
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Conclusions These results indicate that SS-induced ATP release from RBCs causes an 
increase in EC [Ca2+]i and vascular permeability, and that SS-induced NO production can 
be independent of increased EC [Ca2+]i in intact venules. 
Keywords: shear stress; microvessel; permeability 
Non-standard Abbreviations and Acronyms 
SS = shear stress 
EC = endothelial cell 
NO = nitric oxide 
eNOS = endothelial nitric oxide synthase 
RBC = red blood cell 
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INTRODUCTION 
In the circulatory system, sustained fluid shear stress (SS) has been implicated to play 
important roles in maintaining vascular wall endothelium integrity, and changes of SS or 
disrupted flow patterns contribute to the pathogenesis of many disease-associated vascular 
dysfunction.1 Although the effects of SS on endothelial cell (EC) functions have been 
extensively investigated in both cell culture and in intact microvessels, the results are still 
controversial and the detailed mechanisms remain not well understood. Most of the SS-
related studies were conducted in cultured endothelial monolayers, which have provided 
important means to elucidate the relationship between SS and endothelial function.2-7   
However, it has also been recognized that the cultured ECs grown under static conditions 
usually have 10-100 times higher baseline permeability compared to intact microvessels, 
and have been considered as pro-inflammatory phenotype,8 therefore, their responses to 
mechanical forces may not fully replicate in vivo conditions. Additionally, under in vivo 
conditions, the fluid in the vascular system is not a cell-free fluid. It contains blood cells that 
also subject to SS under different flow conditions. Studies on red blood cells (RBCs) have 
indicated that SS plays important roles in triggering RBC to release bioactive agents, such 
as ATP, that regulate many important vascular functions.9-13 However, previous studies of 
the effects of SS on vascular endothelium, either in cultured endothelial monolayers2-7 or 
in individually perfused microvessels,14-16 were mainly conducted in the absence of blood 
cell components, whereas the studies of the effects of SS on blood cells, such as RBCs, 
usually do not involve vascular endothelium.9-13  
Considering current contradictory results relating to the effects of SS on ECs, such as 
the SS-induced  changes of EC [Ca2+]i, the Ca2+ dependence of SS-induced NO production, 
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and the effect of changing of SS on vascular permeability, our study aims to provide a better 
understanding of these issues by focusing on direct comparisons of the effects of SS 
generated by cell-free fluid (i.e. plasma and dextran solutions) and whole blood on EC 
[Ca2+]i, NO production, and EC barrier integrity using individually perfused intact venules in 
rat mesentery. ECs respond differently to constant versus transient changes of SS.1 Our 
studies were focused on the effects of transient increases in SS. The changes of SS were 
generated by changing flow velocity and perfusion pipet diameter and mimic some of the 
geometric or pathological changes that occur in the vasculature in vivo. We first quantified 
the wall SS by measuring the maximal RBC velocity and fluid viscosity using a high-speed 
camera and a cone-plate viscometer. EC [Ca2+]i and nitric oxide (NO) were measured in 
Fura-2 AM and DAF-2 DA loaded venules when the SS was generated by different 
perfusates. EC eNOS activation was evaluated by immunofluorescence staining with 
confocal imaging. SS-induced ATP released from RBCs is measured by bioluminescence 
assay. Changes of microvessel permeability upon changing SS was evaluated by the 
endothelial gap formations using fluorescence microspheres. The involvement of pannexin 
1 channel on RBCs in SS-induced ATP release and its relationship with endothelial Ca2+ 
and microvessel permeability were also investigated.  
  
 
 
76 
 
METHODS 
Animal preparation 
Experiments were carried out on venular microvessels in rat mesenteries. Female Sprague-
Dawley rats (2–3-mo old; 220–250 g body wt; Hilltop Lab Animals, Inc.; Scottdale, PA) were 
used for all of the experiments. Sodium pentobarbital was used for anesthesia and given 
subcutaneously at an initial dosage of 65 mg/kg body weight with an additional 3-mg dose 
given as needed. The trachea was intubated, and a midline surgical incision (1.5–2 cm) was 
made in the abdominal wall. A loop of the ileum was gently extended from the abdominal 
cavity and the mesentery spread over a glass cover slip attached to an animal tray. The 
upper surface of the mesentery was continuously superfused with mammalian Ringer’s 
solution, maintained at 37°C. All experiments were carried out on venular microvessels with 
diameters ranging between 40 to 45 μm. Each experiment was performed on a single 
microvessel with one experiment per animal. The investigation conforms to the Guide for the 
Care and Use of Laboratory Animals (NRC Eighth edition 2010). All procedures were 
approved by the West Virginia University Animal Care and Use Committee. 
Quantification of shear stress in individually perfused venules. 
Wall SS, the tangential force exerted per unit area of fluid-endothelium surface, is determined 
by shear rate and viscosity. Wall Shear rate (γ), determined by mean fluid velocity (Vmean) 
and vessel diameter (D), is calculated by the equation γ = 8Vmean / D.17 A Photron-FASTCAM 
high-speed camera was used to record images at 500 frames/sec for flow velocity 
measurements. ImageJ analysis software with the MTrackJ plugin was used to quantify the 
center line red blood cell velocity (Vmax), the maximum red blood cell velocity in laminar flow 
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parabolic profile. The mean fluid velocity (Vmean) is calculated as Vmax / 1.6.17 Perfusate 
viscosity was measured using a Wells-Brookfield cone/plate digital viscometer (LVTDCP). In 
the designed experiments, a single venular microvessel was cannulated with a glass 
micropipette and perfused with albumin-Ringer solution (control) or other perfusate solutions. 
Hydrostatic pressure, controlled by a water manometer, was applied through the micropipette 
to the microvessel lumen to control the flow rate. Wall shear stress was modulated by 
changing shear rate through changing perfusion pressure or the composition of the 
perfusate.  
Measurements of endothelial [Ca2+]i  
Endothelial [Ca2+]i was measured in individually perfused microvessels using the fluorescent 
Ca2+  indicator fura 2-AM. Experiments were performed on a Nikon Diaphot 300 inverted 
microscope equipped with a Nikon photometry system including photometer head and finder 
(P101), computer-controlled shutter, and filter changer (Lambda 10-2; Sutter Instrument; 
Novato, CA). A rectangular variable diaphragm located in the photometer finder determined 
the size of the measuring window through which the fluorescence intensity (FI) was collected. 
A segment of fura 2-AM-loaded vessel, at least 100 μm away from the cannulation pipet site 
assuring laminar flow, was then positioned within the field of view of the measuring window. 
The size of the window covered about 50 endothelial cells forming the vessel wall. A Nikon 
Fluor lens (x20, numerical aperture, 0.75) was used to collect FI values. The excitation 
wavelengths for fura 2-AM were selected by two narrow-band interference filters (340 ± 5 
and 380 ± 5 nm; Oriel), and the emission was separated with a dichroic mirror (DM400) and 
a wide-band interference filter (500 ± 35 nm; Oriel). The exposure time is 0.25 s. The ratios 
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of the two FI values were converted to Ca2+ concentrations using an in vitro calibration curve. 
A detailed description has been previously reported.18 
Measurements of endothelial nitric oxide  
Endothelial NO production was measured in DAF-2 DA loaded vessels using fluorescence 
imaging. Experiments were performed on a Nikon Diaphot 300 microscope equipped with 
a 12-bit digital CCD camera (ORCA; Hamamatsu) and a computer controlled shutter 
(Lambda 10-2; Sutter Instrument; Novato, CA). A 75-W xenon lamp was used as the light 
source. The excitation wavelength for DAF-2 was selected by an interference filter (480/40 
nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass barrier 
(535/50 nM). All the images were acquired and analyzed using Metafluor software 
(Universal Imaging, West Chester, PA). To minimize the photo-bleaching, a neutral density 
filter (0.5 ND) was positioned in front of the interference filter and the exposure time was 
minimized to 0.12 sec at 1 min intervals. During the experiments, each vessel was first 
perfused with albumin-Ringer solution containing DAF-2 DA (5 µM). Image collection was 
started after 40 minutes of DAF-2 DA perfusion. All images were collected from a group of 
endothelial cells located in the same focal plane of the vessel wall using a Nikon Fluor lens 
(x20, numerical aperture, 0.75). Quantitative analysis was conducted at the individual 
endothelial cell level using manually selected regions of interest (ROIs) along the vessel 
wall. Each ROI covers the area of one individual cell as indicated by the fluorescence 
outline. The tissue autofluorescence was subtracted from all of the measured FIs. Shear 
stress-induced changes in fluorescence intensity (FI) were expressed as (FI/FI0) X 100, 
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where FI0 is control FI level. The NO production rate was calculated as dFI/dt. Details have 
been described previously.19 
RBC preparation and ATP measurement  
Blood was draw from the carotid artery with heparin (20 unit/ml) and was used immediately. 
The blood was diluted to approximately 1% Hct in mammalian Ringer’s solution. The blood 
suspension was then centrifuged at 500 × g for 5 min and the buffy coat removed. This 
procedure was repeated another two times to obtain washed RBCs. Blood samples were 
kept at room temperature throughout experiments. Packed RBCs were resuspended in 1% 
albumin-Ringer’s solution. Immediately following exposure to shear stress in the 
viscometer, RBC samples were removed and were mixed 50/50 with the luciferin/luciferase 
assay mix (Sigma). The ATP level in each sample was measured for 20 sec using a 
luminometer (AutoLumatPlus LB953, Berthold). The relative light unit (I) is proportional to 
the concentration of extracellular ATP. A zero-shear control was taken for each prepared 
solution (I0). The relative ATP release is reported as (I-I0)/I0.  
Immunofluorescence staining and confocal imaging 
The mesentery bearing each perfused vessel was fixed with paraformaldehyde, followed 
by permeabilization with 0.1% Triton X-100 before exposure to the anti-phosphorylated 
eNOS at Ser1177 (Abcam) or Thr495 (Cell Signaling Technology) antibody. The tissue was 
then incubated with Alexa 488-conjugated secondary antibody (Invitrogen) at room 
temperature for 2 h. Confocal images were obtained using a Leica objective x63 (HCX PL 
APO, NA 1.2) with × 1.5 electronic zoom, and the vertical step was 0.3 μm. The mean FI of 
individual endothelial cells was quantified by selecting three one square micron ROIs that 
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within each cell and averaging the Z-axis stack of each ROI, using Leica confocal software. 
The mean of the FI averaged from three stacks of ROIs estimated the individual endothelial 
cell mean FI.  The mean FI for each vessel segment was estimated by averaging the mean 
endothelial cell FIs for three endothelial cells, and represented site specific eNOS 
phosphorylation.  
Visualization of endothelial gap formation in intact microvessels 
We used fluorescent microspheres (FMs) as the marker to identify endothelial gap 
formation. Briefly, each individual microvessel was perfused with a perfusate containing red 
FMs (100 nm, 3.6 ×1011/ml) for 10 min with and without changes in SS. Confocal images 
were collected following 10 min albumin-Ringer perfusion to remove the free FMs from the 
vessel lumen. A stack of confocal images was obtained from each vessel at successive X-
Y focal planes with vertical depth of 0.5 µm using Leica ×25 (NA 0.95) objective. The 
accumulation of FMs at junctions between ECs was analyzed in images from lower half of 
the complete Z-axis image stack of the vessel. The total FI of FM (area x depth x mean 
intensity/pixel) for each vessel segment was quantified as total intensity/surface area of the 
vessel wall under control or shear conditions. Details have been described previously.20  
Measurements of fluid velocity in the perfusion pipette 
To quantify the SS exerted on RBCs when they pass through the narrow perfusion pipette, 
the fluid velocity in the perfusion pipette was measured with Photron-FASTCAM high-speed 
camera at 250~1000 frames/sec. ImageJ analysis software with MTrackJ plugin was used 
to quantify the center line red blood cell velocity (Vmax), the maximum red blood cell 
velocity in laminar flow parabolic profile. The mean fluid velocity (Vmean) is calculated as 
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Vmean = Vmax / 2(1- 8 / R2),21 and shear rate is calculated as 8Vmean / 2R, where R is 
the radius of the certain cross section of a pipette. The power trendline in Excel (Microsoft 
office) was used for regression analysis.  
Solutions and reagents  
Mammalian Ringer’s solution was used for the experiments. The composition of the 
mammalian Ringer’s solution was (mM) 132 NaCl, 4.6 KCl, 2 CaCl2, 1.2 MgSO4, 5.5 
glucose, 5.0 NaHCO3, 20 N-2 hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) 
and Na-HEPES pH 7.4. Albumin-Ringer’s solution (BSA, 10 mg/ml) was used as control 
solution. Fura-2 AM was purchased from Life Technologies, Grand Island, NY. DAF-2 DA 
was purchased from Sigma, St. Louis, MO. All the fluorescent dyes were prepared in 
DMSO for stock solution and at least 1:1000 dilution was made for the final working 
solutions. All of the perfusates containing the test reagents were freshly prepared before 
each cannulation. 
Data analysis and statistics   
All values are means ± SE. Paired t-test was used for paired data analysis. ANOVA was 
used to compare data between groups. A probability value of P < 0.05 was considered 
statistically significant. 
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RESULTS 
Quantification and modulation of wall shear stress in individually perfused 
mesenteric rat venules 
Wall SS is the product of shear rate and viscosity of the moving fluid. To quantify the SS in 
individually perfused venules, we measured the viscosity of each perfusate using 
cone/plate viscometer and calculated the shear rate by measuring velocity of each 
perfusate under different perfusion pressure using high-speed camera. Fig 1A shows one 
of the images captured at 500 frames per second in a blood perfused vessel. Viscosity of 
each perfusate was measured at shear rate of 225 s-1 at 37°C. The mean viscosity of whole 
blood from 9 rats with mean hematocrit at 45.0 ± 0.74% was 4.7 ± 0.12 cP. The viscosity 
of rat plasma was 1.2 ± 0.04 cP (n = 5), and 10% Dextran 70 in 1% BSA solution was 4.6 
± 0.13 cP (n = 3). Since each venule selected for the experiment has relatively constant 
(perfusion pressure minus balance pressure) and shear rate with each perfusate (n = 3 per 
group, Fig 1B). By multiplying the measured viscosity, Fig 1D demonstrates the relationship 
between the net perfusion pressure and wall shear stress with each perfusate. 
Only blood flow generated changes of shear stress induce transient increases in EC 
[Ca2+]i in individually perfused venules 
Studies in cultured ECs and arterioles indicated that intracellular Ca2+ plays an important 
role in wall SS-mediated responses in vascular function.6, 22 In this study we first 
investigated the changes in venular endothelial [Ca2+]i in response to the changes of wall 
SS generated by different perfusates. The mean endothelial [Ca2+]i was 57 ± 4  nM when 
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the vessel was perfused with Ringer’s solution containing 10 mg/ml of BSA at 1.1 Pa steady 
SS. Then the same vessel was recannulated with a micropipette containing whole blood. 
When the SS was increased from 0 to 1.1 Pa or 3.2 Pa, EC [Ca2+]i transiently increased to 
206 ± 14 nM and 315 ± 22 nM, respectively (n = 5 per group). Fig 2A shows the changes 
in EC [Ca2+]i from a representative experiment. However, the identical magnitude changes 
in SS utilizing albumin-Ringer’s solution, plasma, or 10% Dextran70 perfusate did not 
cause significant changes in endothelial [Ca2+]i (Fig 2B-D).  
Both blood and plasma perfused venules show the magnitude of shear-dependent 
EC NO production  
Among currently reported SS-induced vasoactive factors, NO released from ECs is 
considered as the most important factor in the regulation of vascular function. In venular 
microvessels, as demonstrated in previous studies from our group23 and others,24 basal 
NO plays anti-inflammatory roles by preventing leukocyte adhesion and platelet 
aggregation, whereas inflammatory stimuli-induced NO plays a pro-inflammatory role and 
increases microvessel permeability.25 In this study, we further investigated the NO 
responses to the changes in SS in both blood and plasma perfused vessels. Using the NO-
indicator, DAF-2, and fluorescence imaging, we found that changes of SS induced 
magnitude-dependent increases in NO production in both plasma and whole blood 
perfused vessels. When the SS increased from 0 to 1.1 Pa and 0 to 3.2 Pa, the NO 
production rate was 0.19 ± 0.02 AU/min and 0.48 ± 0.10 AU/min in plasma perfused vessels 
(n = 3), and  0.13 ± 0.02 AU/min and 0.24 ± 0.02 AU/min in blood perfused vessels (n = 3, 
Figure 3A and 3B). The higher NO-dependent DAF-2 signal detected in plasma-perfused 
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vessels as compared to blood perfused vessels may be attributed to the scavenging of NO 
by RBCs. 
Shear stress-induced eNOS activation  
To correlate SS-induced NO production with eNOS activation status, we examined eNOS 
phosphorylation at Serine 1177 and Threonine 495 under the same experimental 
conditions as those in which NO was measured using immunofluorescence staining and 
confocal imaging (n = 3 per group). eNOS-Ser1177 phosphorylation showed similar 
responses to blood and plasma perfusion-generated SS, and the levels of changes were 
shear magnitude-dependent (Fig 4A-B). However, shear magnitude-dependent eNOS-
Thr495 dephosphorylation only occurred in blood perfused vessels, and no significant 
changes were found in plasma perfused vessels (Fig 4C-D).  
ATP released from RBCs is responsible for shear stress-induced transient increases 
in EC [Ca2+]i in individually perfused venules 
One of the major differences between whole blood and plasma perfused vessels is the 
presence of blood cells. Since the majority of the blood cells are RBCs, we examined 
whether the presence of RBCs contributes to SS-induced changes in EC [Ca2+]i. Results 
showed that perfusion of vessels with 1% albumin-Ringer perfusate containing 40% 
(volume) of RBCs resulted a similar pattern of shear-induced increases in EC [Ca2+]i to 
those in whole blood perfused vessels. EC [Ca2+]i transiently increased from 76 ± 6 nm to 
218 ± 10 nM and 314 ± 30 nM when SS increased from 0 Pa to 1.1 Pa and 3.2 Pa, 
respectively (n = 3, Fig 5A and B).  
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Several studies have indicated that RBCs release ATP in response to shear, and that a 
pannexin 1 channel on their membrane serves as a mechanical sensor and is responsible 
for the ATP release.9, 26 We examined shear-induced ATP release from RBCs using a cone-
plate viscometer to generate SS and luciferin/luciferase assay to measure ATP. We found 
that SS induced magnitude-dependent ATP release from RBCs, and preincubation of 
RBCs with pannexin 1 inhibitor, carbenoxolone (100 µM), blocked the ATP release (n = 3, 
Fig. 5C). Furthermore, perfusing microvessels with carbenoxolone (100 µM) treated RBCs 
also abolished SS-induced increases in EC [Ca2+]i (Fig 5D). The mean EC [Ca2+]i were 71 
± 21 nM and 80 ± 23 nM when SS was increased from 0 to 1.1 Pa and 3.2 Pa, respectively 
(Fig 5B).  
Shear stress-induced endothelial gap formation  
Our previous study demonstrated that the magnitude of the accumulation of fluorescent 
microspheres (FMs) at junctions between ECs is closely correlated with the degree of 
endothelial gap formation and increased microvessel permeability.20 To determine whether 
the change of SS results in increased microvessel permeability, FMs (100 nm) were added 
to the blood or plasma perfusate to mark the endothelial gap formation upon changing SS. 
We found that only in blood perfused vessels, increase of SS from 0 to 3.2 Pa induced 
significant accumulation of perfused FMs at endothelial junctions and the FI of accumulated 
FMs was 5.1 ± 0.5 times the 0 Pa control (Fig 6A right panel). The identical experimental 
procedures performed in plasma perfused vessels showed no such effect (Fig 6A left panel, 
n = 3). RBC solutions (40% hematocrit) also showed similar effects to blood perfused 
vessels, with the FI of accumulated FMs being 6.9 ± 1.1 times the 0 Pa control (Fig 6B left, 
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n = 5). When the vessels were perfused with 40% carbenoxolone-treated RBCs, the FI of 
accumulated FMs was significantly decreased to 1.5 ± 0.1 times the 0 Pa control value (Fig 
6B right, n = 6). 
Additional shear stress exerted on RBCs when they pass through the perfusion 
pipette  
The identification of the roles of RBCs in shear-induced EC signaling and permeability 
changes led us a further evaluation of the shear forces the RBCs experienced in individually 
perfused microvessels. It has been reported that constricted RBCs from a wide channel to 
a narrow channel in microfluidic devices generated sudden increase of SS on the RBCs, 
which triggers the ATP release from the RBCs.9, 10 Based on those observations, our single 
vessel perfusion technique essentially replicates the shear conditions of the microfluidic 
devices with even larger magnitude changes in SS when the RBCs pass through the 
narrow perfusion pipette during whole blood or RBC perfusion. Therefore, under our 
experimental conditions, RBCs in the perfusate not only experienced the wall shear in the 
vessel lumen, but also experienced a greater transient changes in shear when passing 
through the tip of the perfusion pipette. We hypothesized that shear-induced ATP release 
from RBCs contribute to the shear-dependent increases in endothelial [Ca2+]i. To quantify 
the shear that RBCs experienced when they pass through the perfusion pipette, we 
measured the RBC velocity near the pipette tip as the inner diameter narrowed (Fig 7A).  
Fig 7 B-C shows the mean velocity profile of the RBCs within the perfusion pipette as a 
function of the distance from the pipette tip, a factor linearly associated with the changes in 
pipette diameter.  When the wall shear conditions were increased from 0 to 1.1 Pa and 3.2 
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Pa, respectively, the sharpest change in RBC velocity started at around 150 µm from the 
upstream of the pipette tip (n = 3 for each group) and the maximum shear rate was about 
10 time higher than they experienced in the vessel lumen, which may greatly contribute to 
ATP-induced increases in endothelial [Ca2+]i. 
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DISCUSSION 
Our studies by direct comparisons of intact microvascular responses to SS generated 
by cell-free fluids, such as plasma or solutions containing Dextran 70, with SS generated 
by blood flow demonstrated that under in vivo conditions, the changes of blood flow affect 
endothelium not only by fluid-generated wall SS, but also by shear-induced releases of 
ATP from RBCs. Each component contributes to different EC signaling and affects 
important vascular functions. Our results indicated that an increase of fluid-generated wall 
SS induces increased EC NO production, which does not involve an increase in endothelial 
[Ca2+]i. However, under in vivo conditions, i.e. in blood perfused vessels, the increased 
shear exerted on RBCs induces shear-magnitude dependent ATP release. This SS-
dependent ATP release from RBCs causes increases in EC [Ca2+]i and endothelial gap 
formation, an indication of increases in microvessel permeability. By linking the effects of 
wall SS on endothelium with the effects of shear-induced ATP release from RBCs on 
endothelium, our study provided new insight about how changes of blood flow affect 
vascular functions in vivo.   
Mechanisms of shear stress-induced increases in EC [Ca2+]i: the role of shear-
induced ATP release from RBCs  
It has been controversial for decades whether exposure of EC to flow is accompanied 
by elevated cytoplasmic [Ca2+]i.6, 27 Our results provided the first evidence in intact 
microvessels that the changes of SS in plasma or similar viscous dextran-albumin-Ringer-
perfused vessels do not cause increases in EC [Ca2+]i, and the SS-induced increases in 
EC [Ca2+]i only occur in blood perfused microvessels and require the presence of RBCs. 
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Our experiments that measured SS-induced ATP release from RBCs in vitro in combination 
with quantifications of SS exerted on RBCs through single vessel perfusion also provided 
mechanistic explanations for RBC involved SS-dependent increases in EC [Ca2+]i in intact 
microvessels.   
Previous studies using an in vitro microfluidic approach or microbore tubing reported 
that RBCs release ATP upon exposure to increased SS or cell deformation, and the amount 
of ATP released was directly proportional to the number of RBCs and the magnitude of the 
changes in channel diameter or flow rate.10, 11, 13, 28, 29, The pannexin 1 channel has been 
reported to act as a mechanical sensor on the membrane surface of RBCs and to mediate 
ATP release, as inhibition of pannexin 1 attenuates SS-induced ATP release.9, 26 However, 
these studies did not involve endothelial cells, and to date the effect of SS-induced ATP 
release from RBCs on the endothelium has not been well explored, especially in intact 
microvessels. Our experiments using cone-plate viscometry to generate SS on RBCs in 
the presence and absence of a pannexin 1 inhibitor further confirmed the role of the 
pannexin 1 channel in the shear-dependent ATP release from RBCs. We previously 
in EC [Ca2+]i and microvessel Lp.30 In this study, we not only quantified the wall SS with 
different perfusates when the endothelial cell [Ca2+]i and NO production were measured, 
but also analyzed the additional SS exerted on RBCs via micropipet perfusion of  individual 
microvessels. In addition to changes in shear within the lumen of the perfused microvessel, 
RBCs experienced marked increases in SS when they passed through the narrow tip of 
the perfusion pipette (Fig 7),  The shear effects of micropipette perfusion  was similar to the 
narrow constriction design used in microfluidic channel studies, in which shear-induced 
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ATP release was detected from RBCs passing through the constrictions.9, 10 Based on 
those studies and our in vitro measurements of SS-induced ATP release from RBCs, we 
predict that under our experimental conditions the increased SS on RBCs caused by 
moving through narrow perfusion pipette and increased fluid velocity to raise wall SS 
induced significant amount of ATP release from RBCs, and this increased ATP release 
contributes to the observed increases in EC [Ca2+]i in blood perfused vessels. Our 
experiments using carbenoxolone, a selective inhibitor of pannexin 1, which abolished SS-
induced ATP release in vitro and SS-dependent increases in EC [Ca2+]i in blood perfused 
intact microvessels (Fig 5C), provide further evidence that SS-induced increases in EC 
[Ca2+]i are directly associated with ATP released from RBCs.. Although some cultured cell 
studies reported SS-induced ATP release from ECs resulting in increases in EC [Ca2+]i,31 
based on our EC [Ca2+]i measurements in plasma and dextran 70-perfused vessels, any 
SS-induced EC released ATP was insufficient to cause increases in EC [Ca2+]i in intact 
microvessels. 
Shear stress induced EC NO production and eNOS activation 
Although it has been well recognized that the changes of SS induce NO production from 
ECs, the signaling mechanisms remain unclear, especially because there is a lack of in 
vivo evidence. Prior in vitro studies on the role of Ca2+ in SS-mediated NO production have 
been controversial. Some studies reported that SS-induced NO was independent of 
external Ca2+, but was mediated by increases in cytoplasmic Ca2+ via Ca2+ release from 
intracellular stores.6, 32 Others reported that flow-induced NO release was blocked by 
removal of extracellular Ca2+ or the application of Ca2+ and calmodulin (CaM) antagonists.7, 
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33 There are also studies reported that flow-induced NO occurred independently of changes 
in intracellular [Ca2+]i.34 These inconsistencies could be the result of the differences in 
cultured cell species, ATP concentrations in culture media, and the applied flow patterns. 
A study conducted in rabbit lungs indicated that mechanical force-induced NO synthesis 
requires ATP release from RBCs.12 Our measurements of both NO and endothelial [Ca2+]i 
responses in blood and plasma perfused intact microvessels demonstrated that similar 
increases in fluid generated wall SS, with and without RBCs, induce increases in NO 
production.  However, only increasing SS with perfusion solutions with substantial numbers 
of RBCs increased endothelial [Ca2+]i. These observations indicate that SS-induced NO 
can be independent of increases in endothelial [Ca2+]i. The increases in SS-induced EC 
[Ca2+]i observed in blood-perfused microvessels are dependent on the magnitude of SS, 
but they are attributed to EC responses to shear-induced releases of ATP from RBCs. Our 
result that blocking ATP release from RBCs abolished SS-induced increases in endothelial 
[Ca2+]i supports this conclusion. 
To further evaluate the Ca2+-independence of SS-induced NO production,, we 
assessed the activation status of eNOS following the same experimental procedures as 
those EC [Ca2+]i and NO were measured using immunofluorescence staining and confocal 
imaging. Two separate amino acid residues are reported to be particularly important in 
regulating eNOS activity: a serine residue Ser1177 and a threonine residue Thr495.35 Cultured 
EC and isolated protein studies indicated that eNOS-Ser1177 phosphorylation represents a 
Ca2+-independent regulatory mechanism for activation of eNOS,36 but the 
dephosphorylation of Thr495-associated eNOS activation depends on increased EC 
[Ca2+]i.37 Our results that SS-induced eNOS-Ser1177 phosphorylation occurred in both 
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plasma and whole blood perfused vessels, while SS-induced eNOS-
Thr495 dephosphorylation only occurred in blood perfused microvessels, are consistent with 
the molecular characterization of each of the eNOS activation sites. These results further 
support the hypothesis that the changes in wall SS in the absence of RBCs activate eNOS 
via a Ca2+-independent mechanism, indicating the wall SS-induced NO production can be 
independent from increases in EC [Ca2+]i. In the presence of RBCs, the SS-induced 
activation of eNOS involves both Ca2+ dependent and independent mechanisms with Ca2+ 
dependent eNOS activation being the result of ATP-induced increases in EC [Ca2+]i.  
Shear stress and microvessel permeability 
Although studies in individually perfused microvessels in both frog and rat mesenteries 
have consistently demonstrated flow-dependent increases in permeability to small solutes, 
such as K+ and sodium fluorescein,38, 39 the results of flow-induced changes in permeability 
to macromolecules and fluid (Lp) remain conflicting.14-16, 40 Studies using isolated perfused 
pig coronary venules reported perfusion rate-dependent increases in permeability to 
albumin.40  In individually perfused frog mesenteric venules, one study showed that the 
initial measured Lp value was correlated with  the blood flow rate prior to the vessel 
cannulation,15 but others using the similar techniques reported no changes in Lp upon 
changes in flow velocity or wall SS.14, 16, 38 Based on the measurements of flow-induced 
permeability to small solutes, the changes occurred rapidly.38, 39 It is a great technical 
challenge to quantitatively measure SS-induced hydraulic permeability following the 
traditional single vessel perfusion and occlusion technique.21 To date, all of studies using 
single vessel perfusion techniques were conducted in the absence of RBCs (i.e. <1% RBCs 
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which serve as velocity markers), and therefore assess only cell-free fluid generated wall 
SS. To overcome the technical difficulties of assessing SS-induced permeability to fluid and 
macromolecules, especially in the presence of RBCs, we directly evaluated EC junctional 
changes in response to changed SS using FMs as marker to assess EC gap formation.20 
Our previous studies demonstrated that when FMs (100 nm diameter) were perfused into 
platelet activating factor (PAF) stimulated rat venules, the amount of accumulated FMs at 
EC junctions serves as an index for the dimension of gap formation between ECs (validated 
by electron micrograph), and is temporally correlated with the time course of PAF-induced 
Lp changes.20 Using this method, our current results demonstrated that changes of SS 
generated by cell-free fluid (plasma or dextran 70-BSA-solutions) showed no significant 
increase in accumulation of FMs at vascular walls, indicating no additional EC gap 
formation. However, changes of SS generated with perfusion solutions containing 40% 
RBCs increased EC gap formation, reflected by increased FM accumulation at EC 
junctions.  Significantly, this increased junctional accumulation of FMs was abolished when 
RBCs were pre-treated with a pannexin 1 inhibitor, suggesting endothelial gap formation is 
directly linked with RBC released ATP and ATP-induced increases in EC [Ca2+]i. SS-
induced NO production alone (in the absence of RBC released ATP) showed no effect on 
EC [Ca2+]i or EC gap formation. Based on our previous studies, all agonist-induced 
permeability increases are associated with increases in EC [Ca2+]i.8, 18 Our present results 
suggest that the agonist-induced Ca2+-dependent permeability regulation also applies to 
RBC associated shear force-induced changes in microvessel barrier function.       
Summary 
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The main contribution of this study is that we demonstrated the response of endothelial 
cells to changes in SS in intact venules. Our results revealed that under in vivo conditions, 
ECs not only respond to fluid generated wall SS, but also to ATP released by RBCs in 
response to shear and that this ATP plays important roles in altering EC integrity and 
vascular permeability. The studies presented in this paper provide the basic mechanisms 
that may explain and predict the roles of changing SS in different vasculature under both 
physiological and pathological conditions. Variations in vascular geometry involving 
narrowed regions, such as blood entry from small capillary to venules or at vascular 
converging points, may expose the RBCs to high SS, cause the release of ATP, and 
increase EC [Ca2+]i and EC gap formation in downstream vessels. Under pathological 
conditions, such as arterial stenosis due to local atherosclerotic plaque formation, or 
mechanical injury-induced local vascular remodeling and cell proliferation, may cause 
similar responses which would exacerbate local inflammation and vascular damage. 
Although further validation under those conditions is needed, our observations indicate that 
the effect of SS-induced ATP release from RBCs should not be underestimated or omitted 
when SS-induced changes in EC function is studied.  
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FIGURES AND FIGURE LEGENDS 
      Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
Figure 1. Shear stress measurement in intact mesenteric venules. A) High speed 
camera image of the blood flow in a rat mesenteric venule. B) Relationship of shear rate to 
perfusion pressure using different perfusate solutions. C) Summary of different perfusate 
viscosity measured by cone-plate viscometer D) Relationship of shear stress to perfusion 
pressure using different perfusate solutions. 
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Figure 2. Blood flow generated-shear stress induced transient increase in EC [Ca2+]i 
in individually perfused venules. A) The time course of blood flow generated-shear 
stress induced EC [Ca2+]i changes from a representative experiment. B-D) The time 
courses of 1% BSA, plasma and 10%Dextran70 generated-shear stress induced EC [Ca2+]i 
changes from respectively representative experiments E) Summary data show that only 
whole blood perfusion at different perfusion pressure induced shear-magnitude dependent 
transient EC [Ca2+]i increase (n = 5 for the blood group, n = 3 for the other groups) * 
indicates a significant increase from the 1%BSA control, ** indicates a significant increase 
from 1.1 Pa group generated by blood perfusion 
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Figure 3 
 
 
 
 
 
 
 
Figure 3. Shear stress-induced EC NO production in rat mesenteric venules A) Time 
course of representative experiments showed that both the onset of plasma and whole 
blood perfusion-generated sudden change of shear stress induced shear-magnitude 
dependent increases of EC NO production. B) Summary data from three vessels from each 
group showed the rate of NO production over different magnitude of shear stress.  * 
indicates a significant increase from the from the 1.1 Pa group generated by the same 
perfusate, ‡ indicates a significant increase from blood perfusion group at same shear 
stress magnitude. 
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Figure 4 
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Figure 4. EC eNOS phosphorylation (eNOS-Ser1177 and eNOS- Thr495) in response to 
different magnitudes of shear stress generated by either blood or plasma perfusion 
in the perfused venules. A) Confocal images of shear-dependent phosphorylation of 
eNOS-Ser1177 in blood and plasma perfused vessels. C) Confocal images of shear-
dependent dephosphorylation of eNOS- Thr495 in blood perfused group but not in plasma 
ones. B&D) Summary of the fluorescence changes under different experimental conditions 
(n = 3 for each group).* indicates a significant increase from the 0 Pa control, ** indicates 
a significant increase from the lower shear stress group generated by the same perfusate, 
† indicates a significant decrease from the 0 Pa control. †† indicates a significant decrease 
from the 1.1 Pa group generated by blood perfusion.  
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Figure 5. 
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Figure 5. ATP release from erythrocytes are required for shear stress-induced 
transient increase in EC [Ca2+]i in individually perfused venules. A) Summary of ATP 
measurement from red blood cells exposing to shear stress in the presence and absence 
of carbenoxolone B-C) Representative experiments shows 40%RBC in albumin ringer 
solution perfusion induced shear-magnitude dependent EC [Ca2+]i transient increase, while 
carbenoxolone incubated RBC solution using the same experiment procedure greatly 
diminished the EC [Ca2+]i increase D) Summary data show that carbenoxolone abolished 
the RBC solution induced EC [Ca2+]i transient increase. (n = 3 for each group). * indicates 
a significant increase from the 1%BSA control, ** indicates a significant increase from the 
1.1 Pa group generated by the same perfusate. † indicates a significant decrease from the 
RBC perfusion group at the same shear stress magnitude. 
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Figure 6 
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Figure 6. Blood flow and RBC solution perfusion generated-sudden change of shear 
stress induced endothelial cell gap formation. A) Representative confocal images 
shows blood but not plasma perfusion generated sudden change of shear stress from 0 to 
3.2 Pa induced gap formations B) Representative confocal images shows 40% RBC 
solution generated sudden change of shear stress induced gap formations. While pre-
incubation of RBC solution with cabenoxolone abolished the gap formation. C) 
Quantificantion of the fluorescence intensity (FI) of accumulated fluorescent microspheres 
(FMs) accumulation at endothelial junction. (n = 3 for Plasma 0 Pa, Plasma 3.2 Pa and 
Blood 0 Pa, n = 6 for Blood 3.2 Pa and 40%RBC + CBX, n = 5 for 40%RBC 3.2 Pa) * 
indicates a significant increase from the 0 Pa control, † indicates significant decreases from 
the RBC perfusion group.  
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Figure 7.  
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Figure 7. Fluid velocity measurement inside cannulation pipette. A) A representative 
image shows the dimension of a cannulation pipette. The changes in the pipette inner 
diameter are relatively linear within 800 µm distance from the cannulation pipette tip where 
fluid velocity was measured.  B-D) Flow velocity and shear rate along the cannulation 
pipette when the vessel lumen wall shear stress was suddenly changed from 0 to 1.1 and 
3.2 Pa, respectively. 
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ABSTRACT 
Glycocalyx (GCX), a layer of proteoglycans covering the endothelium, has been implicated 
as a mechanical sensor in sensing the changes in shear stress (SS) in vitro. Though acute 
hyperglycemia has been reported to impair GCX in human by indirect volume estimation, 
the direct experimental evidence and how the impaired GCX affects SS-mediated 
endothelial function in vivo remain to be demonstrated. The objective of this study is to 
identify the changes in GCX in microvessels of streptozotocin-induced diabetic rats and 
evaluate the associated changes in sensing SS and SS-induced nitric oxide (NO) 
production in individually perfused venules of diabetic rats. GCX is visualized either by 
electron microscope (EM) or by lectin fluorescence labeling. EC NO production was 
quantified in DAF-2 DA loaded vessels using fluorescence imaging. Microvessels of 
diabetic rats showed degraded GCX by both EM and confocal images, a similar observation 
found in pronase (0.1 mg/ml, 3 min) treated microvessels. Unexpectedly, the EC NO 
production in response to blood flow-generated changes in SS in diabetic vessels was 
significantly higher than that in normal vessels. The NO production rate in normal vessels 
were 0.13 ± 0.02 and 0.24 ± 0.02 AU/min at 11 and 32 dyn/cm2. In contrast, the NO 
production rate of diabetic vessel in response to the same magnitude changes of SS were 
0.25 ± 0.05 and 0.37 ± 0.03 AU/min, respectively. These findings were also supported by 
an increased NO production observed in pronase treated normal venules. Our results 
indicate that the impaired GCX in diabetic microvessels enhances EC response to 
mechanical force and potentiates NO production.  
Key Words: glycocalyx, diabetic, microvessel permeability, nitric oxide 
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INTRODUCTION 
     Wall shear stress is the tangential force exerted per unit area of the blood-endothelium 
surface. How the endothelium senses changes in shear stress in intact microvessels has 
not been well explored. The glycocalyx has been implicated as a mechanical sensor for 
changes in shear stress. Using an indirect volume estimation method, endotoxemia and 
hyperglycemia have been reported to cause damage to the glycocalyx coating on the 
endothelial cell surface in human. However, direct experimental evidence and how the 
impaired glycocalyx (GCX) affects shear stress-mediated endothelial function in vivo 
remain to be demonstrated. A study in frog microvessels showed increases in hydraulic 
conductivity (Lp) to be associated with the partial digestion of the endothelial glycocalyx. 
Our recent study found increased basal permeability and enhanced permeability responses 
to inflammatory mediators in venules of diabetic rats. Whether the increased permeability 
in diabetic rats is the result of an impaired glycocalyx remains unknown. Here we conducted 
experiments to test the hypothesis that hyperglycemia-induced damages to the glycocalyx 
contribute to the increases in microvessel permeability in diabetic rats. Among the currently 
reported vasoactive factors induced by shear stress, NO released from ECs is considered 
as the most important factor in the regulation of vascular function. In the arterioles, it 
regulates vascular tone, peripheral resistance, and tissue perfusion. In venular 
microvessels, as demonstrated in previous studies from our lab and others, basal NO plays 
anti-inflammatory roles by preventing leukocyte adhesion and platelet aggregation, 
whereas stimuli-induced excessive NO production plays a pro-inflammatory role and 
increases microvessel permeability. Therefore, this study was focused on shear stress-
induced NO production under normal and diabetic conditions. 
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METHODS 
Animal preparation 
Experiments were carried out on venular microvessels in rat mesenteries. All procedures 
and animal use were approved by the Animal Care and Use Committee at West Virginia 
University. Female Sprague-Dawley rats (2–3-mo old; body wt 220–250 g; Hilltop 
Laboratory Animals; Scottdale, PA) were anesthetized with pentobarbital sodium given 
subcutaneously. The initial dosage was 65 mg/kg of body weight with an additional 3 mg 
dose given as needed. The trachea was intubated, and a midline surgical incision (1.5–2 
cm) was made in the abdominal wall. The mesentery was gently moved out of the 
abdominal cavity and spread over a glass cover slip attached to an animal tray. The upper 
surface of the mesentery was continuously superfused with mammalian Ringer solution. 
The temperature of the superfusate was maintained at 37°C. All experiments were carried 
out on venular microvessels with diameters ranging between 40 and 50 μm. Each 
experiment was performed on a single microvessel with one experiment per animal. 
Fluorescence imaging of endothelial nitric oxide production   
Endothelial NO production was measured in DAF-2 DA loaded vessels using fluorescence 
imaging. Experiments were performed on a Nikon Diaphod 300 microscope equipped with 
a 12-bit digital CCD camera (ORCA; Hamamatsu) and a computer controlled shutter 
(Lambda 10-2; Sutter Instrument; Novato, CA). A 75-W xenon lamp was used as the light 
source. The excitation wavelength for DAF-2 was selected by an interference filter (480/40 
nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass barrier 
(535/50 nM). All the images were acquired and analyzed using Metafluor software 
(Universal Imaging, West Chester, PA). To minimize the photo-bleaching, a neutral density 
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filter (0.5 ND) was positioned in front of the interference filter and the exposure time was 
minimized to 0.12 sec at 1 min intervals. During the experiments, each vessel was first 
perfused with albumin-Ringer solution containing DAF-2 DA (5 µM). Image collection was 
started after 40 minutes of DAF-2 DA perfusion. All images were collected from a group of 
endothelial cells located in the same focal plane of the vessel wall using a Nikon Fluor lens 
(x20, numerical aperture, 0.75). Quantitative analysis was conducted at the individual 
endothelial cell level using manually selected regions of interest (ROIs) along the vessel 
wall. Each ROI covers the area of one individual cell as indicated by the fluorescence 
outline. The tissue autofluorescence was subtracted from all of the measured FIs. Shear 
stress-induced changes in fluorescence intensity (FI) were expressed as (FI/FI0) X 100, 
where FI0 is control FI level. The NO production rate was calculated as dFI/dt. Details have 
been described previously.1 
Electron microscopy 
The changes of glycocalxy was examined with electron microscopy. Each vessel was 
perfused with Alcian Blue 8GX (0.05%) to stain the glycocalyx, while the upper surface of 
the mesentery was superfused with a fixative solution. After fixation, a small panel of the 
mesentery that contained the perfused microvessel was dissected and placed in the same 
fixative at 4°C overnight. The specimens were then rinsed in 0.1 M phosphate buffer and 
permeabilized with 50% ethanol. The samples were postfixed and transferred into 
propylene oxide, and embedded in epon. Photomicrographs were taken on a JEOL 1220 
transmission electron microscope 
Confocal imaging 
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Glycocalyx distrubution was also visualized with confocal imaging  using FITC-conjugated-
lectin (FITC-BS-1) that can specifically bind to components of the endothelial glycocalyx. 
Leica TCS SL confocal microscope equipped with microvessel perfusion rig was used to 
collect images. Each stack of images was acquired by optical sectioning at successive X-
Y focal planes with vertical depth of 0.5 µm using Leica X 25 objective (HC Plan APO, NA 
0.95) and 1024 x 1024 scanning format. Leica software was used for image acquisition and 
image analysis. 
Visualization of Endothelial gaps formation in intact microvessels 
We used fluorescent microspheres as the marker to identify endothelial gap formation. 
Briefly, each individual microvessel was perfused with a perfusate containing red 
fluorescent microspheres (FMs, 100 nm, 3.6 ×1011/ml) with and without the sudden change 
of shear stress for 10 min. Confocal images were collected following 10 min albumin-Ringer 
perfusion to remove the free FMs from the vessel lumen. A stack of confocal images was 
obtained from each vessel at successive X-Y focal planes with vertical depth of 0.5 µm 
using Leica ×25 (NA 0.95) objective. The accumulation of FMs at junctions between 
endothelial cells was analyzed in images from lower half of the complete Z-axis image stack 
of the vessel. The total FI of FM (area x depth x mean intensity/pixel) for each vessel 
segment was quantified as total intensity/surface area of the vessel wall under control or 
shear conditions. Details have been described previously.2  
Solutions and reagents  
Mammalian Ringer’s solution was used for the experiments. The composition of the 
mammalian Ringer’s solution was (mM) 132 NaCl, 4.6 KCl, 2 CaCl2, 1.2 MgSO4, 5.5 
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glucose, 5.0 NaHCO3, 20 N-2 hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) 
and Na-HEPES pH 7.4. Albumin-Ringer’s solution (BSA, 10 mg/ml) was used as control 
solution. Fura-2 AM was purchased from Life Technologies, Grand Island, NY. DAF-2 DA 
was purchased from Sigma, St. Louis, MO. All the fluorescent dyes were prepared in 
DMSO for stock solution and at least 1:1000 dilution was made for the final working 
solutions. All of the perfusates containing the test reagents were freshly prepared before 
each cannulation. 
Data analysis and statistics   
All values are mean ± SE. Paired t-test was used for paired data analysis. ANOVA was 
used to compare data between groups. A probability value of P < 0.05 was considered 
statistically significant.  
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RESULTS 
 
Impaired glycocalyx in diabetic rat venules   
Cultured cell studies showed that glycocalyx degradation is correlated with decreases 
in shear stress-induced NO production and with increases in permeability of EC 
monolayers.3-5 Decreased glycocalyx volume has been reported in diabetic patients.6 A 
study in frog microvessels showed increases in hydraulic conductivity (Lp) to correlate with 
the partial digestion of the endothelial glycocalyx.7 However, whether the hyperpermeability 
in diabetic rats is the result of impaired glycocalyx has not been studied in vivo. We 
hypothesize that the hyperglycemia caused glycocalyx damage may contribute to the 
increases in microvessel permeability in our STZ-induced diabetic rats. The electron 
micrograph with Alcian Blue 8GX staining shown in Fig 1A directly shows that the 
glycocalyx was impaired in microvessels of diabetic rats. In addition to the electron 
microscopic studies, we developed another method to visualize the glycocalyx distribution 
using confocal imaging with FITC-conjugated-lectin (FITC-BS-1) that can specifically bind 
to components of the endothelial glycocalyx.8 Fig 1B lower left panel  is a single scan of the 
FITC-BS-1 labeled glycocalyx of a normal vessel (focal plane at the center of the vessel 
lumen) and Fig 1B upper panel is the projection image from the lower half X-Y z-stack 
images. Fig 1B also shows the disappearance of glycocalyx after 5 min of pronase 
(0.1mg/ml) treatment. 
Impaired glycocalyx enhances EC NO production to shear stress 
The glycocalyx has been indicated as a mechanotransduction sensor to the fluid shear 
stress in many in vitro studies.9-12 Using enzyme degradation of its specific components 
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impaired the shear stress induced NO production and increased permeability in vitro.13 In 
the proposed studies, we will investigate the role of the glycocalyx in the regulation of shear 
stress-induced changes in microvessel functions in intact venules. Since NO is one of most 
importance EC vascular factor induced by shear stress, we first investigate the change of 
EC NO to shear stress in diabetic rats with impaired glycocalyx. Our results in Fig 2 showed 
enhanced NO production when normal blood was perfused into diabetic venules. The NO 
responses to different magnitudes of shear stress were even higher than those measured 
in pronase treated normal venules. These results suggested that both a damaged 
glycocalyx and altered ECs may contribute to this enhanced EC NO production to shear 
stress. 
Increased microvessel permeability to shear stress in diabetic rats 
Excessive NO production induced by inflammatory mediators contributes to an increase 
in microvessel permeability and plays a pro-inflammatory role. 14-16 Thus, our next step is 
to investigate whether the microvessel permeability changes to shear stress in enhanced 
in diabetic rats. Our previous study found that the changes in the magnitude of FM 
accumulation closely correlated with the time course of PAF-induced increases in hydraulic 
conductivity (L(p)), indicating that the accumulation of FM reflects the degree of EC gaps 
formation and related microvessel permeability.2 In Fig 3, venules of diabetic rats perfused 
with 1% BSA (control) at 1.1 Pa shows moderate gap formation. Blood perfusion-generated 
shear stress at 3.2 Pa significantly potentiated the EC gaps formation (compare the right 
panels between A and B), indicating increased sensitivity of diabetic vessels in response 
to mechanical force. 
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DISCUSSION 
Wall shear stress is the tangential force exerted per unit area of the blood-endothelium 
surface. The glycocalyx, a layer of proteoglycans covering the endothelium, has been 
indicated to be a mechanotransduction sensor for changes of shear stress.12 Impaired 
glycocalyx has been suggested may directly contribute to the increased leukocyte 
adhesion, hyperpermeability, and other microvascular dysfunctions associated with 
diabetes and other cardiovascular diseases. In our present study, we found the impaired 
glycocalyx increases the endothelial susceptibility to shear stress, which resulting in 
augmented nitric oxide production in microvessels of diabetic rats.  
The experiments were conducted in individually perfused microvessels with undisturbed 
surrounding circulation, which we consider extremely important. In order to translate the 
remarkable knowledge gained from in vitro studies into clinical therapeutic applications, it 
is essential to evaluate cellular and molecular mechanisms in their native state. 
Multidimensional protein identification revealed that 41% of proteins expressed in vivo are 
not detected in vitro, indicating that distinct in vivo protein expression is apparently 
regulated by the tissue microenvironment and cannot yet be duplicated in standard cell 
culture.17 This is specifically important for glycocalyx studies, because the glycocalyx under 
static cultured cell growth is not as well developed as that under physiological conditions.  
The endothelial cell glycocalyx has been reported to have 0.2 to 0.5 µm thickness lining 
the luminal surface of all blood vessels.18 A human study indicated that glycocalyx volume 
is reduced in hyperglycemia patients.6 However, they estimated systemic glycocalyx 
volume by comparing the distribution of glycocalyx permeable tracer (dextran 40) with 
glycocalyx impermeable tracer (using labeled erythrocytes). This methodology raises some 
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concerns for its validity.19 No direct evidence had previously been demonstrated for an 
impaired glycocalyx in diabetes. Here, we directly visualize the loss of glycocalyx in diabetic 
animal using electron microscopy and immunofluorescence confocal imaging. 
The glycocalyx has been indicated as a mechanotransduction sensor to the fluid shear 
stress in many in vitro studies.9-12 Using enzyme degradation of its specific components 
impaired the shear stress induced NO production and increased permeability in vitro.13 Our 
data suggested that removing the glycocalyx enhanced EC NO production, which indicated 
that impaired glycocalyx enhances EC responses to mechanical force. Interestingly, we 
also found the NO responses to different magnitudes of shear stress were even higher than 
those measured in pronase treated normal venules. It suggested that besides the damaged 
glycocalyx, the altered ECs in diabetic rats may also contribute to this enhanced EC NO 
production to shear stress. 
Nitric oxide (NO) is mainly produced from endothelial cells driving from shear stress in 
the vasculature under physiological condition. It has been currently demonstrated to play 
important roles in the regulation of microvessel barrier function. Basal level of endothelial 
NO production protects vascular wall from leukocytes adhesion, platelets aggregation, 
thrombosis, and atherosclerotic plaque formation.20 On the other hand, inflammatory 
mediator-stimulated increased NO production in endothelial cells is essential for increasing 
the microvessel permeability.21, 22 Our previous study on individually perfused intact 
venules showed that platelet activating factor (PAF) induces transient increases in 
microvessel permeability through both Ca2+ and NO dependent pathway.23 However, the 
exactly role of NO in regulating microvessel permeability is still unknown.  
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Our future study will further investigate the causal relationship among impaired 
glycocalyx, enhanced shear stress induced NO production, and enhanced vascular 
permeability, as well as the involved cellular mechanisms.  
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FIGURES AND FIGURE LEGENDS 
   Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Direct visualization of glycocalyx in rat venules using EM and confocal 
imaging A: The electron micrograph with Alcian Blue 8GX staining of GCX shows impaired 
GCX in a rat mesenteric venule.  B: Confocal images illustrating glycocalyx by FITC-
conjugated-lectin (FITC-BS-1) staining in intact mesenteric venules. Upper panel is the 
projection image from the lower half X-Y z-stack images. Lower panel is a single scan of 
the FITC-BS-1 labeled glycocalyx of a normal vessel (focal plane at the center of the vessel 
lumen). Fluorescence intensity is significantly decreased in diabetic and pronase 
(0.1mg/ml, 5 min) treated venules, indicating the loss of glycocalyx layer at endothelial 
surface.  
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Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Endothelial NO production in response to blood flow-generated shear 
stress is significantly enhanced in both diabetic and pronase treated rat mesenteric 
venules. Shear stress was changed from 0 to 1.1 Pa or 3.2 Pa, in each experiment, 
respectively. The graph shows that the NO production rates in diabetic and pronase treated 
vessels were significantly higher than that in a normal vessel in response to the same range 
of changes in shear stress, indicating the impaired glycocalyx increased endothelial 
sensitivity to mechanical force (N=3 in each group). 
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Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Shear stress-induced EC gap formation is enhanced in venules of diabetic 
rats. Accumulation of fluorescent microspheres (FMs, red) is used to mark endothelial 
gaps. Images were collected after the start of changing shear stress with different 
perfusate. Each image is the projection of the lower half of the z-stack images. A) Venules 
of normal rats perfused with 1% BSA (control) at 1.1 Pa shows no FM accumulation and 
perfusion of blood at 3.2 Pa induces small magnitude of EC gaps; B) Venules of diabetic 
rats perfused with 1% BSA (control) at 1.1 Pa shows moderate gap formation, which may 
represent the moderate basal Lp increase found in diabetic rats and can be independent 
from the shear stress (left panel). A sudden change of blood perfusion-generated shear 
stress to 3.2 Pa significantly potentiated the EC gaps formation (compare the right panels 
between A and B), indicating increased sensitivity of diabetic vessels in response to 
mechanical force. 
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ABSTRACT  
A physiologically realistic microvessel model for studying complex vascular phenomena, 
such as endothelial cell signaling and barrier functions, is much needed to biologists 
because of critical constraints of current microvessel models having the resolution at 
individual cell levels, in vitro models are lack of stable and mature endothelium with 
appropriate barrier functions, while in vivo animal studies are often too complex and have 
high experimental costs. Microfluidic technologies have enabled in vitro studies to closely 
simulate the in vivo microvessel environment with sufficient complexity. However, there are 
still gaps of knowledge and a generalized lack of validation of these models as adequate 
model of a functional microvessel. In this paper, we presented an engineered microfluidic 
microvessel model, demonstrated in vitro formation of microvessels that recapitulate key 
features of the microvessels in vivo, and validated its utility for biological applications. Our 
microvessel model illustrates unique capabilities in advanced micromanufacturing and 
microfluidic technologies to create a model mimicking the dimensions of in vivo 
microvessels with long-term, continuous perfusion control, as well as real-time high-quality 
imaging capability. Cells in our model maintain their phenotype, viability, proliferation with 
proper barrier functions, and respond to flow shear force and inflammatory stimuli. In 
particular, primary human umbilical vein endothelial cells were successfully cultured along 
the entire inner surface of the microchannel network with morphologies close to those 
reported in venular vasculature and well-developed VE-cadherin junctions throughout the 
channels. The endothelial cell responses to shear stresses were quantified under different 
flow shear conditions. Furthermore, we successfully measured agonist-induced changes in 
intracellular Ca2+ concentration [Ca2+]i and nitric oxide (NO) production in individual 
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endothelial cell levels using our model. The results were similar and comparable to those 
derived from individually perfused intact venules. With the in vivo validation of its 
functionalities, our microfluidic model demonstrates a great potential for biological 
applications and bridging the gaps between in vitro and in vivo microvascular research. 
Key words: microfluidics, HUVECs, microvessel network, shear responses, ATP, [Ca2+]i, 
nitric oxide  
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INTRODUCTION  
The development of microfluidic devices has been embraced by engineers over two 
decades. However, the adaptation and application of microfluidics in mainstream biology is 
still lacking. According to the recent summary, the majority publications of microfluidics are 
still in engineering journals (85%).1 The equivalent or improved performance of microfluidic 
devices is not convincing enough for many biologists to switch from current state-of-the-art 
techniques such as Transwell assay and macroscale culture dish/glass slide.1, 2 The most 
common way to replicate certain features of in vivo shear stress by biologist includes 
parallel flow chamber and cone and plate viscometer.3 Microfluidics has the advantage to 
provide a solution that has not been addressed by those macroscale approaches, such as 
developing a more physiologically relevant in vitro model. In this paper we continue our 
previous efforts in developing an in vitro functional microvessels that could provide a 
platform for the study of complex vascular phenomena.4 
A physiologically realistic microvessel model is able to overcome certain critical 
constraints of the current in vitro models, such as creating a stable and mature endothelium 
with appropriate barrier functions. Additionally, the advanced models, that enable a close 
simulation of in vivo environment with sufficient complexity, could work as artificial 
surrogates for curtailing high experimental costs and complexities associated with animals 
and in vivo studies.5 Several groups have pioneered in the development of advanced 
microvessel models, which applied micromanufacturing and microfluidic techniques, used 
either polymer or hydrogel to template the growth of vascular endothelial cells (ECs), co-
cultured ECs with other vascular cells, demonstrated cell viability, and appropriate functions 
in angiogenesis and thrombosis.6-9 Nonetheless, prior methodologies did not demonstrate 
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and quantify some key features for microvessels, such as intracellular Ca2+ concentration 
([Ca2+]i) and nitric oxide (NO) production in cultured microvessels with well-developed 
endothelial junctions. NO, is essential for controlling vascular tone and resistance in 
arterioles, and regulating vascular wall adhesiveness and permeability in venules.10 
Additionally, the endothelial [Ca2+]i plays an important role in microvessel permeability,11,12 
angiogenesis13 and morphogenesis.14 However, in microfluidic based systems, there are 
very limited reports for measurements of [Ca2+]i and NO production.15, 16, 19, 20 Some studies 
reported DAF-2DA loaded endothelial cells from a microfluidic network,17,18 and ATP-
induced NO production was reported on cultured bovine pulmonary artery endothelial cells 
within a straight microfluidic microchannel. However, there is a lack of reports of 
quantification of time-dependent changes in NO production under basal and stimulated 
conditions, and agonist-induced changes in [Ca2+]i in endothelialized microchannels. 
 In this paper, we presented an in vitro formation of a microvessel network that 
recapitulates key features of microvessels in vivo. The microfabrication technique 
accurately controls the dimensions of the developed microchannels in microscales which 
mimicking those of in vivo microvessels. In addition, continuous microfluidic perfusion is 
able to control the mass transfer and flow shear stresses precisely. A confluent endothelial 
monolayer was formed and fully covered inside the entire microchannel network. To further 
validate the functionalities of developed microvessels, the vascular endothelial adherens 
junctions were confirmed by the VE-cadherin immunofluorescence staining. We also 
evaluated the cell morphology changes in response to different patterns of shear stress. 
Additionally, endothelial [Ca2+]i and NO production were quantitatively measured under 
control and stimulated conditions. 
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MATERIAL AND METHODS 
Design and Fabrication  
 
The microchannel network designed in this paper was a three-level branching 
microchannels as shown in Fig. 1. The smallest width of the microchannel was 100 µm. 
Standard photolithography was used for the master mold fabrication and 
polydimethylsiloxane (PDMS) soft lithography was used for the microfluidic microchannel 
network fabrication (Fig. 1).21 Briefly, a silicon wafer was rinsed with acetone and methanol 
and baked on a hot plate (150°C) over 30 minutes for dehydration (Fig. 1(a)). SU-8 
photoresist (SU8-2050, Microchem) was spun-coated over the pre-cleaned silicon wafer 
with a thickness of 100 µm, and then the wafer was baked on the hot plate at 65°C and 
95°C, respectively (Fig. 1 (b)). The designed patterns were transferred from a film mask to 
the SU-8 thin film after the UV light exposure (OAI model 150, Fig. 1 (c)), post baking, and 
the development as shown in Fig. 1 (d). After the hard baking at 150°C, the developed 
patterns as the master mold were ready for the PDMS soft lithography. The PDMS (Slygard 
184, Dow Chemical) was mixed at a weight ratio of 10:1, and cast onto the master mold to 
replicate the microchannel patterns (Fig. 1 e). PDMS was cured and peeled off from the 
master mold after it was baked in an oven at 60°C for 3 hours. The inlet and the outlet, 
which were used for the cell loading, tubing connections, media and reagent perfusion, and 
waste collection, were punched with a puncher (1 mm, Miltex). In a typical confocal 
microscopy system, the objective lens with high numerical apertures (NA) has a limited 
working distance in a range of a few hundred microns.22 Therefore, to incorporate the 
microfluidic devices to the confocal system, the number 1 glass coverslip (thickness of 130-
160 µm, Fisher Scientific) spun-coated with a thin layer of PDMS (thickness of 20 µm) was 
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used  as  the substrate for the device bonding (Fig. 1 (f)). A permanent bonding was created 
to seal the microchannels completely after oxygen plasma treatment (50 W, 100 mtorr) of 
PDMS for 30 seconds. 
Numerical Simulation of Shear Stress Distribution 
 To analyze shear stress distributions inside the microchannel networks, a fluid dynamic 
analysis model using COMSOL multiphysics software (Version 4.0.0.982, COMSOL Inc.) 
was built to numerically simulate shear flows.21 Incompressible Navier-Stokes equations 
were chosen as governing equations for the fluids, and no-slip wall boundary condition was 
set along the internal surface of the microchannels except for the inlet and the outlet. 
Cell Culture 
 
Primary human umbilical vein endothelial cells (HUVECs) were purchased from Lonza. 
The cells were maintained in MCDB 131 culture medium (Gibco, Life Technologies) 
supplemented with 10% fetal bovine serum, 1% L-glutamine, 0.1% Gentamicin, 0.05% 
bovine brain extract (9mg/mL), 0.25% endothelial cell growth supplement (3mg/mL), and 
0.1% heparin (25mg/mL) in tissue cultured flasks, which were pre-coated with 0.2% gelatin. 
The cell culture was performed in a humidified atmosphere of 5% CO2 at 37°C, and the 
cells between passage 2 and passage 5 were used for this study. When the cultured 
HUVECs reached confluent, the cells were harvested and re-suspended in 8% Dextran 
(mol wt 70,000, Sigma) diluted with MCDB 131 culture medium. Dextran was used to 
increase the medium viscosity for better controlling cell seeding inside the microchannels. 
 Prior to cell loading, the device was treated with oxygen plasma for 3-5 minutes to reduce 
the hydrophobicity of inner surfaces of PDMS microchannels. The device was then loaded 
with deionized water and sterilized under the UV light exposure for 8 hours in a laminar 
  
 
 
135 
 
biosafety hood. After UV sterilization, the device was rinsed with 1× phosphate buffered 
saline (PBS), coated with fibronectin diluted in 1×PBS (100 µg/mL, Gibco, Life 
Technologies), and incubated at 4°C inside a refrigerator for overnight. After this, the device 
was rinsed with 1×PBS again to remove the fibronectin solution completely, and loaded 
with cell media. Finally, the device was incubated for 15 minutes at 37°C and was ready 
for cell loading. 
 To load the cells, a droplet (10 µL) of HUVECs was placed at the inlet, and a slow flow 
was created by either tilting the device, or placing a glass pasteur pipette (the inner 
diameter of the pipets is around 1.5 mm, VWR) at the outlet. Capillary action through the 
microchannels was gently introduced by the glass pipette and the cells slowly moved along 
the media into the channels. The key for a successful cell loading was to control the flow 
velocity very slowly, otherwise, most of the cells cannot attach uniformly inside the 
microchannels. After 15-20 minutes incubation in the incubator, the attached cells can be 
visually confirmed under the microscope. An additional loading can be performed if 
necessary. After a satisfied cell seeding density was reached, the device was gently rinsed 
with the media to remove the dextran solution. A complete attachment requires five to six 
hours. Long-term continuous perfusion was set up by a syringe pump system (Harvard 
Apparatus) with a steady flow rate of 0.35 µL/min. The perfusion can last up to two weeks, 
and can be adjusted to maintain different flow patterns if necessary.4 
Confocal Fluorescence Imaging of Intracellular Calcium Concentration  
 
Fluo-4 was selected for confocal Ca2+ imaging. Image acquisition was conducted on a 
Leica TCS SL confocal microscope with a Leica ×25 objective (NA: 0.95). An argon laser 
(488 nm) at 50% power was used for excitation, and the emission band was 510–530 nm. 
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To minimize photobleaching, fluo-4 images were collected using a 512 × 512 scan format 
at a z-step of 2 μm. Stacks of images were collected from the same group of HUVECs with 
20 seconds intervals. Each network device was first loaded with fluo-4 AM (5 μM) for 40 
minutes followed by albumin-Ringer perfusion to rinse the lumen fluo-4 AM before control 
images were collected. Quantitative analysis of endothelial [Ca2+]i at the individual 
endothelial cell level was conducted using manually selected ROIs along the 
microchannels. Each ROI covered the area of one individual endothelial cell, as indicated 
by the fluorescence outline. The changes in endothelial [Ca2+]i at the cellular levels were 
quantified by calculating the mean FI of each stack of ROIs after the subtraction of the 
background auto fluorescence. The percent change in FI was expressed as FI/FI0*100, 
where FI0 was the initial baseline FI of fluo-4. Details have been described previously.25 
Confocal Fluorescence Imaging of Nitric Oxide Production  
 
Endothelial NO levels were investigated at the cellular levels in the microvessel network 
using DAF-2 DA, a membrane-permeable fluorescent indicator for NO, and fluorescence 
imaging. Experiments were performed on a Nikon Diaphod 300 microscope equipped with 
a 12-bit digital CCD camera (ORCA; Hamamatsu) and a computer controlled shutter 
(Lambda 10-2; Sutter Instrument; Novato, CA). A 75-W xenon lamp was used as the light 
source. The excitation wavelength for DAF-2 was selected by an interference filter (480/40 
nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass barrier 
(535/50 nM). All the images were acquired and analysed using Metafluor software 
(Universal Imaging).  
Each network device was first perfused with albumin-Ringer solution containing DAF-2 
DA (5 μM) for 35~40 minutes before collecting DAF-2 images. DAF-2 DA was present in 
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the perfusate throughout the experimental duration. All images were collected from a group 
of HUVECs located in the same focal plane using a Nikon Fluor lens (x20, NA: 0.75). Data 
analysis was conducted at the individual endothelial cell level using manually selected 
regions of interests (ROIs). Each ROI covered the area of one individual cell as indicated 
by the fluorescence outline. The PDMS auto fluorescence was subtracted from all of the 
measured fluorescence intensities (FIs). The basal NO production rate was calculated from 
the slope of the mean FI increase during albumin-Ringer perfusion after DAF-2 loading was 
reached the steady state. The changes in FIDAF upon ATP stimulation were expressed as 
the net changes in FI (∆FI). FI was expressed in arbitrary units (AU) measured with identical 
instrumental settings. The rate of FIDAF change was derived by first differential conversion 
of cumulative FIDAF over time. Details have been described previously.23, 24 
Immunofluorescent Staining 
 
HUVECs were fixed in 2% paraformaldehyde solution (Electron Microscopy Science) 
for 30 minutes by perfusing the fixing solution into the network. The cells were blocked with 
1 mg/mL bovine serum albumin (BSA, Sigma) in PBS solution for 30 minutes followed by 
permeabilization with 0.1% Triton X-100 (Sigma) for 5 minutes. The primary antibody (VE-
cadherin) was perfused at 4 °C for overnight. Then, the second antibody (Alexa488, 
Invitrogen) was perfused for 1 hour at the room temperature. Finally, the cell nuclei were 
stained with DRAQ 5 (Biostatus). The F-actin staining followed the similar fixing, blocking, 
and permeabilizing procedures, and then stained with phalloidin-Alexa 633 (Sigma) for 10 
minutes, followed by the DRAQ5 nuclei staining. Fluorescent images were obtained using 
an inverted optical microscope (Nikon Ti-E inverted live-cell imaging microscope) and a 
confocal laser-scanning microscope (Leica TCS SL), respectively. 
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Cell Morphology Analysis in Response to Shear Stress 
To study the actin cytoskeleton and HUVECs morphology changes under shear 
stresses, different scenarios were performed to vary the culture and shear flow conditions. 
Detailed experimental conditions are listed in Table 1. Briefly, after initial seeding three 
different flow conditions were set for the same patterned networks in different devices as 
shown in Table 1: Low shear culture, low shear test (LSC-LST); Low shear culture (till the 
ECs reached confluence), high shear test (LSC-HST); and high shear culture, high shear 
test (HSC-HST). The transition from low shear stress to high shear stress was gradually 
applied by programming a step function (10 steps of increase in 18 hours) using the syringe 
pump (Harvard Apparatus). 
Quantitative analysis was performed to examine HUVEC morphology changes (i.e. 
aspect ratio and cell surface area) in responses to different levels of shear stresses. The 
aspect ratio was defined as the length of the primary axis (d1, along the flow direction) 
divided by the length of the secondary axis (d2, perpendicular to the flow direction). A cell 
was considered as an ellipse shape and the corresponding cell surface area was calculated 
as 
πd1d2
4
. 
Data analysis and statistics 
For statistical analysis, data was presented as the mean ± standard error (SE) and each 
individual experiment was performed at least three times (n≥3). Statistical significance of 
detected difference between groups was tested using the single-factor ANOVA.  
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RESULTS  
Characterization of the Endothelial Adherens Junctions in Microvessels Developed 
in Microchannel Network 
With the initial cell loading concentrations of 2 ~ 4 × 106 cells/mL, confluent monolayers 
developed within 3-4 days under a constant flow of culture media. Fig. 2 shows the confocal 
images of endothelial cell F-actin and cell nuclei staining at different regions of the network 
in the same device, which illustrates that HUVECs successfully cultured the entire inner 
surface of the network to confluence. We also examined the junctional formation between 
ECs as an indication of endothelial barrier function. VE-cadherin, an important protein for 
the maintenance and control of the junctions between endothelial cells, was immune-
stained in the entire microchannel. Fig. 3 shows the confocal images of VE-cadherin and 
nuclei staining at different regions of the microchannel. The confocal images illustrate that 
VE-cadherin was well developed throughout the entire network (Fig. 3 b-d), demonstrating 
a continuous distribution between ECs with less lattice-like structure that often appeared in 
statically cultured endothelial monolayers.26 The VE-cadherin distribution in the 
microchannels is closer to that demonstrated in intact microvessels,12 suggesting that the 
continuous flow condition during cell growth provide a better environment for appropriate 
EC spreading, viability, proliferation, and formation of junctions.  
Endothelial Cell Responses to Shear Stress 
To quantify the shear stress, which the endothelium lining the microchannels 
experienced under our experimental conditions, we conducted a numerical simulation. The 
calculated wall shear stresses were 1.0 dyne/cm2 under the flow rate 0.35 µL/min, and 10 
  
 
 
140 
 
dyne/cm2 under the flow rate 4.05 µL/min within the selected regions in the devices as 
shown in Fig. 4a-b. 
Flow related shear stress has been shown to induce changes in cell shape and 
cytoskeletal structure of vascular ECs in vivo and in vitro.27, 28 In this study, we evaluated 
the cytoskeletal rearrangement of F-actin fibers and cell shape changes in response to 
three patterns of flow related shear stress within the microchannel networks: continuous 
low shear without a change (LSC-LST); low shear culture with high shear exposure (LSC-
HST); and continuous high shear exposure (HSC-HST). The flow rate and correlated shear 
stress under each condition are listed in Table 1. Under the LSC-LST conditions, about 
70% of the cells show cobblestone pattern with dominated peripheral F-actin, and only 30% 
of the HUVECs showed elongated cell shape with increased central stress fibers aligned 
along the flow direction. Under LSC-HST and HSC-HST conditions, about 50% of the cells 
were elongated with distinct stress fibers along the flow direction. In each scenario, the cell 
shape aspect ratio in non-aligned cells was about 1.5 ± 0.03 and the aligned cells was 3.97 
± 0.19, 3.93 ± 0.22 and 3.95 ± 0.19 in LSC-LST, LSC-HST, and HSC-HST, respectively. 
Fig. 4c-g shows representative images from each group and the quantifications of their 
changes in morphology, including aspect ratio and cell surface areas, in those aligned and 
non-aligned cells, respectively. The aligned cells in high shear stress test groups (LSC-
HST and HSC-HST) demonstrated significantly reduced surface areas (1855 µm2 and 1234 
µm2) compared to those cells under low shear stress conditions (LSC-LST, 2202 µm2, Fig. 
4).  
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Measurements of Endothelial Calcium Concentration ([Ca2+]i) in response to ATP 
Increases in endothelial [Ca2+]i have been demonstrated to play important roles in the 
regulation of a variety of microvessel functions including endothelial barrier function, i.e. 
microvessel permeability. In individually perfused microvessels, inflammatory mediator 
commonly induces transient increases in endothelial [Ca2+]i followed by transient increases 
in microvessel permeability. To validate the biological functions of the microvessels 
developed under flow in our model, we applied the method developed in individually 
perfused intact microvessels25, 29 to the microvessels developed in the microchannel 
network and quantitatively measured the changes in endothelial [Ca2+]i when the 
microvessel was exposed to ATP. Experiments were conducted in four devices with fluo-4 
loaded endothelial cells. When ATP (10 µM) was perfused to each device, [Ca2+]i in all 
endothelial cells under the view reached a peak at 35 ± 10 seconds with the mean peak 
[Ca2+]i at 187 ± 22% of the control. Representative fluo-4 images and the fluorescence 
quantification are shown in Fig. 5. 
Measurement of ATP-induced Nitric Oxide Production 
In intact venules, it has been demonstrated that inflammatory mediator-induced 
increases in endothelial [Ca2+]i was associated with increased NO production, and both 
increased endothelial [Ca2+]i and NO production contribute to increases in microvessel 
permeability.24, 25 With demonstrated ATP-induced increases in endothelial [Ca2+]i, we 
further measured NO production in response to ATP in DAF-2 loaded endothelial cells 
lining the microchannels. 
When ATP (10 µM) was added, the rate change in ATP-induced NO production was 
measured with continuous DAF-2 DA perfusion.23 Each device was first perfused with 
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albumin-Ringer solution containing DAF-2 DA (5 μM) for 35~40 minutes before collecting 
images. After the loading phase, the rate change of FIDAF under control conditions was 0.15 
± 0.05 AU per min, which was close to the basal NO production rate measured in intact rat 
mesenteric venules.10, 23, 30 When ATP (10 µM) was added to the perfusate, the rate change 
in FIDAF was significantly increased. The peak rate of FIDAF increase was 1.18 ± 0.37 AU 
per min. The increased FIDAF returned to the control level after 10~15 minutes of ATP 
exposure. Data were derived from 3 devices with a total of 35 ROIs and 11 to 12 ROIs per 
vessel. NO donor, sodium nitroprusside (SNP), was added at the end of each experiment 
to verify the sufficiency of DAF-2 in the cells and the responsiveness of DAF-2 to NO. Fig. 
6 shows the quantification of time-dependent changes in FIDAF and correlated images from 
an individual experiment. The changes in slopes of the FIDAF indicate the changes in NO 
production rates before and after ATP stimulation. Images in Fig. 6 (b) illustrate the ATP-
induced cumulated increases in FIDAF at 10 minutes of ATP exposure. 
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DISCUSSION 
Our study presented the in vitro formation of a microvessel network using a microfluidic 
device and characterized endothelial junctions, cellular responses to shear stresses, and 
quantitatively measured the changes in endothelial [Ca2+]i and NO production before and 
after exposure to ATP. The results demonstrated that this engineered microvessel network 
recapitulates the key aspects and fundamental functions of in vivo venules, and reveals its 
promising utility for biological applications including studies with human samples. 
With advanced microfabrication techniques, the flexibility to create patterns and scale 
sizes provides users with arbitrary design options to mimic the geometries of in vivo 
microvasculature, which allows the functional studies involved in complex flow patterns 
found at vessel bifurcations and in regions of high curvature that occur in vivo. This 
microfluidic microvessel network with thin PDMS film layer bonded on a thin glass substrate 
(average total thickness is 170 µm) allows excellent light transmission and easy adaptation 
to both bright field and fluorescence microscopy when using short working distance and 
large numerical aperture objectives. Our study demonstrated that this device is capable for 
real-time and high-resolution imaging to detect changes in intracellular molecules and cell 
morphology using fluorescent markers, which is a necessary feature for biological studies. 
This modification is a further progress of applying our previous studies using 
endothelialized microvessel network.4, 21 
The main difference of using this microchannel network compared with traditional cell 
culture is that the cells, instead of growing under static conditions at 2-dimensional flat 
surface, were growing in a three dimensional channel with continuous flow, which made 
the cell culture environment closer to the in vivo situation. The numerical simulation 
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provides an accurate estimation of the wall shear stress distribution. Based on the channel 
dimensions and simulation, the applied shear stress was easily controlled within the range 
of venous system (1 to 10 dyne/cm2).31, 32 Our study characterized the biological functions 
of these cultured microvessels under basal and stimulated conditions, and validated its 
utility for biological applications. Our results indicated that the endothelial cells grown under 
flow conditions form better monolayers with well-developed junctions between endothelial 
cells as that demonstrated by VE-cadherin staining. As shown in Fig. 2, the HUVECs 
completely covered the entire inner surfaces of the channels including the corners and 
formed a completely enclosed network. Most importantly, the VE-cadherin staining showed 
a uniformly distributed band between endothelial cells within the network, which is similar 
to that observed in intact venules,12, 33 and distinct from the intricate lattice-like structure 
commonly found in statically cultured endothelial monolayers.34 
The major technical improvement for biological and physiological application reported 
in this study is the quantitative measurements of agonist-induced changes in endothelial 
[Ca2+]i and NO production at individual cell levels in a well-developed microvessel network. 
Studies in individually perfused intact microvessels indicated that inflammatory mediator-
induced increases in endothelial [Ca2+]i is essential for increases in microvessel 
permeability and that the magnitude of the [Ca2+]i determines the degree of permeability 
increases.29, 45-48 In addition, agonist-induced Ca2+/calmodulin-dependent endothelial nitric 
oxide synthase(eNOS) activation and NO production have been shown to play important 
roles in the regulation of microvessel permeability.24, 25, 49 In this study, we directly applied 
the methods developed in individually perfused intact microvessels23, 29 to this cultured 
microvessel network and conducted parallel studies to those performed in the intact 
  
 
 
145 
 
microvessels in vivo. Currently the uses of microfluidics to study intracellular calcium50, 51 
and NO responses52 have been reported by a few investigators. However, the calcium 
studies were either from suspended leukemic cells50 or from non-confluent osteoblasts.51 
Though ATP-induced NO has been reported in BPAEC cultured microfluidic device, there 
was no characterization of the junctions of endothelial cells in which NO was measured and 
no temporal resolution of NO production was analysed in that study.52 In our study, we 
choose ATP as the representative agonist to study receptor-mediated changes in 
endothelial [Ca2+]i and NO production. ATP can be released by red blood cells, aggregated 
platelets, and injured tissue or under inflammatory conditions. The increased levels of ATP 
cause the release of endothelial-derived relaxing factor and trigger the synthesis of 
prostacyclin, and increase in microvessel permeability by increasing endothelial [Ca2+]i.48, 
53, 54 The action of ATP is primarily via the purinergic P2y receptor expressed on most types 
of endothelial cells.55, 56 The calcium measurements using fluo-4 as indicator in the 
microvessel network showed similar responses to what we found in intact microvessels.25, 
48 As for NO measurements using DAF-2 DA, we need to recognize the specific manner of 
DAF-2 chemical conversion in the presence of NO and conduct data analysis 
accordingly.23, 57 DAF-2 DA is membrane permeable and diffuses freely into the cells driven 
by concentration gradient and is then hydrolyzed by cytosolic esterase to form DAF-2. 
Intracellular DAF-2 is less membrane permeable due to its polarity, and is designed to be 
trapped inside the cells. Because the fluorescence chemical transformation of DAF-2 by 
NO is irreversible,57 the detected NO-sensitive fluorescence with DAF-2 represents a 
cumulative production of NO. The slope of the FIDAF curve represents the NO production 
rate and the plateau indicates the termination of NO production instead of the actual NO 
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concentration in the cells. To present the real-time course of NO production, df/dt, the NO 
production rate, was calculated based on the differential conversion of that regression 
equation (shown in Fig. 5a). Using this method, our study presented the basal NO 
production rate and the changes in NO production after exposure to ATP in HUVECs-
developed microvessels in the microfluidic device with temporal and spatial resolution for 
the first time. The results are comparable to those derived from individually perfused intact 
venules. These studies provide an in vivo validation of the functional aspect of engineered 
microvessel network, which is instrumental for the utility of this device to the development 
of biological applications. 
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CONCLUSIONS 
These results demonstrated in vitro formation of a microvessel network that 
recapitulates key features of microvessels in vivo and validate its utility for biological 
applications. The fabrication process of the microchannels was simple and straightforward 
to lower the barrier for biologists. The cell seeding and culture with constant perfusion 
method was user friendly to most researchers and easy to replicate. Cells in our model 
keep their phenotype, viability, proliferation with proper barrier functions, and respond to 
flow shear force and inflammatory stimuli. Comparing to other conventional in vitro models, 
our model is more physiological realistic. In particular, HUVECs were successfully grown 
to confluence throughout entire microchannels under well-controlled conditions. The model, 
including in vitro growth endothelialized microchannels and the flow control, mimics 
microscaled dimensions of in vivo microvessels and continuous flow patterns. 
Immunofluorescent staining of VE-cadherin demonstrated the formation of vascular 
endothelial junctions, an indication of well-maintained endothelial restrictive barrier 
functions. HUVECs responded to different physiologically relevant flow shear stresses and 
inflammatory stimuli. The endothelial [Ca2+]i, basal NO, and the changes in NO production 
rate in response to ATP were real-time measured and quantified at individual cellular level 
in Fluo 4 and DAF-2 loaded microvessels, respectively. The transient [Ca2+]i responses and 
increased NO production in response to agonist application are similar to those observed 
in individually perfused intact microvessels. The developed microvessel model has the 
potential to bridge the gap between over-simplified in vitro tests and more expensive and 
labour-intensive in vivo animal models for the microvascular signalling and functional 
studies. It offers valuable quantitative insights into how biophysical and biochemical 
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properties influence vascular biology and pathophysiology, serves as the complements for 
in vivo animal studies. Because the cultured endothelial cells can be from human tissues, 
a well characterized device will be suitable for studies of interactions between human blood 
components with microvessels formed by human endothelial cells under physiological and 
pathological conditions.  
Acknowledgements 
This work was supported by the National Science Foundation (NSF-1227359) and by 
WV EPSCoR program (EPS-1003907) funded by the National Science Foundation (Liu, 
Y.); and by National Heart, Lung, and Blood Institute grants HL56237 and HL084338 (He, 
P.) and American Heart Association Great Rivers Affiliate 12PRE11470010 pre-doctoral 
fellowship (Xu, S.). The microfabrication work was performed in Shared Research Facilities 
(Cleanroom facilities) and Microfluidic Integrative Cellular Research on Chip Laboratory 
(MICRoChip Lab) at West Virginia University. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
149 
 
REFERENCE 
1. E. K. Sackmann, A. L. Fulton and D. J. Beebe, Nature, 2014, 507, 181-189. 
2. E. Berthier, E. W. Young and D. Beebe, Lab on a Chip, 2012, 12, 1224-1237. 
3. J.-J. Chiu and S. Chien, Physiological reviews, 2011, 91, 327-387. 
4. X. Li, S. Mearns, M. Martins-Green and Y. Liu, Journal of visualized experiments: JoVE, 
2012, e50771-e50771. 
5. J. El-Ali, P. K. Sorger and K. F. Jensen, Nature, 2006, 442, 403-411. 
6. G. M. Price, K. H. Wong, J. G. Truslow, A. D. Leung, C. Acharya and J. Tien, 
Biomaterials, 2010, 31, 6182-6189. 
7. Y. Zheng, J. Chen, M. Craven, N. W. Choi, S. Totorica, A. Diaz-Santana, P. Kermani, B. 
Hempstead, C. Fischbach-Teschl and J. A. López, Proceedings of the National 
Academy of Sciences, 2012, 109, 9342-9347. 
8. M. Tsai, A. Kita, J. Leach, R. Rounsevell, J. N. Huang, J. Moake, R. E. Ware, D. A. 
Fletcher and W. A. Lam, The Journal of clinical investigation, 2012, 122, 408-418. 
9. L. L. Bischel, E. W. Young, B. R. Mader and D. J. Beebe, Biomaterials, 2013, 34, 1471-
1477. 
10. S. Xu, X. Zhou, D. Yuan, Y. Xu and P. He, American Journal of Physiology-Heart 
and Circulatory Physiology, 2013, 305, H1484-H1493. 
11. M. H. Zadeh, C. A. Glass, A. Magnussen, J. C. Hancox and D. O. Bates, 
Microcirculation, 2008, 15, 605-614. 
12. D. Yuan and P. He, Journal of Applied Physiology, 2012, 113, 1110-1120. 
13. L. Munaron, Recent patents on anti-cancer drug discovery, 2006, 1, 105-119. 
14. M.-J. Lee, S. Thangada, K. P. Claffey, N. Ancellin, C. H. Liu, M. Kluk, M. Volpi, R. I. 
Sha'afi and T. Hla, Cell, 1999, 99, 301-312. 
15. T. D. Oblak, P. Root and D. M. Spence, Analytical Chemistry, 2006, 78, 3193-3197. 
16. S. Letourneau, L. Hernandez, A. N. Faris and D. M. Spence, Anal Bioanal Chem, 
2010, 397, 3369-3375. 
17. M. Tsai, A. Kita, J. Leach, R. Rounsevell, J. N. Huang, J. Moake, R. E. Ware, D. A. 
Fletcher and W. A. Lam, J Clin Invest, 2012, 122, 408-418. 
18. S. Kim, H. Lee, M. Chung and N. L. Jeon, Lab Chip, 2013, 13, 1489-1500. 
19. B. Melchior and J. A. Frangos, Am J Physiol Cell Physiol, 2012, 303, C467-473. 
20. M. A. Corson, N. L. James, S. E. Latta, R. M. Nerem, B. C. Berk and D. G. Harrison, 
Circ Res, 1996, 79, 984-991. 
21. Z. Huang, X. Li, M. Martins-Green and Y. Liu, Biomedical microdevices, 2012, 14, 
873-883. 
22. H. E. Keller, in Handbook Of Biological Confocal Microscopy, ed. J. B. Pawley, 
Springer US, 2006, pp. 145-161. 
23. X. Zhou and P. He, American Journal of Physiology-Heart and Circulatory 
Physiology, 2011, 301, H108-H114. 
  
 
 
150 
 
24. L. Zhu and P. He, American Journal of Physiology-Heart and Circulatory Physiology, 
2005, 288, H2869-H2877. 
25. X. Zhou and P. He, American Journal of Physiology-Heart and Circulatory 
Physiology, 2011, 301, H1788-H1797. 
26. F. Orsenigo, C. Giampietro, A. Ferrari, M. Corada, A. Galaup, S. Sigismund, G. 
Ristagno, L. Maddaluno, G. Y. Koh, D. Franco, V. Kurtcuoglu, D. Poulikakos, P. Baluk, 
D. McDonald, M. Grazia Lampugnani and E. Dejana, Nat Commun, 2012, 3, 1208. 
27. B. L. Langille, J. J. Graham, D. Kim and A. I. Gotlieb, Arterioscler Thromb, 1991, 11, 
1814-1820. 
28. M. Sato and T. Ohashi, Biorheology, 2005, 42, 421-441. 
29. P. He, S. N. Pagakis and F. E. Curry, Am J Physiol, 1990, 258, H1366-1374. 
30. X. Zhou, D. Yuan, M. Wang and P. He, American Journal of Physiology-Heart and 
Circulatory Physiology, 2013, 304, H82-H93. 
31. H. H. Lipowsky, in Flow-Dependent Regulation of Vascular Function, Springer, 
1995, pp. 28-45. 
32. A. M. Malek, S. L. Alper and S. Izumo, Jama, 1999, 282, 2035-2042. 
33. D. Yuan, S. Xu and P. He, Am J Physiol Heart Circ Physiol, 2014, 307, H44-53. 
34. J. A. Ukropec, M. K. Hollinger and M. J. Woolkalis, Experimental cell research, 2002, 
273, 240-247. 
35. E. Tzima, M. Irani-Tehrani, W. B. Kiosses, E. Dejana, D. A. Schultz, B. Engelhardt, 
G. Cao, H. DeLisser and M. A. Schwartz, Nature, 2005, 437, 426-431. 
36. T. Nagel, N. Resnick, W. J. Atkinson, C. F. Dewey Jr and M. A. Gimbrone Jr, Journal 
of Clinical Investigation, 1994, 94, 885. 
37. H. Morawietz, R. Talanow, M. Szibor, U. Rueckschloss, A. Schubert, B. Bartling, D. 
Darmer and J. Holtz, The Journal of physiology, 2000, 525, 761-770. 
38. P. Feugier, R. Black, J. Hunt and T. How, Biomaterials, 2005, 26, 1457-1466. 
39. L. Chau, M. Doran and J. Cooper-White, Lab Chip, 2009, 9, 1897-1902. 
40. B. R. Blackman, G. Garcia-Cardena and M. A. Gimbrone, Jr., J Biomech Eng, 2002, 
124, 397-407. 
41. D. E. Berardi and J. M. Tarbell, Cell Mol Bioeng, 2009, 2, 320-331. 
42. Y. Xia, M. Prawirasatya, B. C. Heng, F. Boey and S. S. Venkatraman, Journal of 
materials science: Materials in medicine, 2011, 22, 389-396. 
43. D. M. McDonald, American Journal of Physiology-Lung Cellular and Molecular 
Physiology, 1994, 10, L61. 
44. F. Orsenigo, C. Giampietro, A. Ferrari, M. Corada, A. Galaup, S. Sigismund, G. 
Ristagno, L. Maddaluno, G. Y. Koh and D. Franco, Nature communications, 2012, 3, 
1208. 
45. F. E. Curry, FASEB J, 1992, 6, 2456-2466. 
46. P. He and F. E. Curry, Am J Physiol, 1991, 261, H1246-1254. 
47. P. He and F. E. Curry, J Appl Physiol (1985), 1994, 76, 2288-2297. 
  
 
 
151 
 
48. P. He, X. Zhang and F. E. Curry, Am J Physiol, 1996, 271, H2377-2387. 
49. X. Zhou and P. He, Cardiovasc Res, 2010, 87, 340-347. 
50. T. Xu, W. Yue, C. W. Li, X. Yao and M. Yang, Lab Chip, 2013, 13, 1060-1069. 
51. S. Kou, L. Pan, D. van Noort, G. Meng, X. Wu, H. Sun, J. Xu and I. Lee, Biochem 
Biophys Res Commun, 2011, 408, 350-355. 
52. T. D'Amico Oblak, P. Root and D. M. Spence, Anal Chem, 2006, 78, 3193-3197. 
53. R. S. Sprague, J. J. Olearczyk, D. M. Spence, A. H. Stephenson, R. W. Sprung and 
A. J. Lonigro, Am J Physiol Heart Circ Physiol, 2003, 285, H693-700. 
54. R. J. Mannix, T. Moatter, K. A. Kelley and M. E. Gerritsen, Am J Physiol, 1993, 265, 
H675-680. 
55. G. R. Dubyak and C. el-Moatassim, Am J Physiol, 1993, 265, C577-606. 
56. T. D. Carter, T. J. Hallam, N. J. Cusack and J. D. Pearson, Br J Pharmacol, 1988, 
95, 1181-1190. 
57. H. Kojima, N. Nakatsubo, K. Kikuchi, S. Kawahara, Y. Kirino, H. Nagoshi, Y. Hirata 
and T. Nagano, Anal Chem, 1998, 70, 2446-2453. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
152 
 
FIGURES AND FIGURE LEGENDS 
 
 
Figure. 1 The schematic fabrication procedures for the microfluidic microchannel 
network. (a) A pre-cleaned silicon substrate; (b) SU-8 photoresist was spun-coated onto 
the silicon wafer; (c) The photoresist was exposed to UV light through the photomask; (d) 
The developed microchannel network pattern was used as the master mold; (e) The PDMS 
mixing solution was cast onto the master mold and cured; (f) The inlet and the outlet were 
punched and the microchannel device was bonded onto the substrate. 
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Figure. 2 The representative confocal images show the HUVECs successfully 
cultured throughout the inner surfaces of the entire microchannel network. (a) The 
schematic image of the network with selected regions as shown in b-d; (b-d) HUVECs 
were stained with F-actin and cell nuclei in each region, where b1, c1 and d1 show the 
top surfaces of the channel, respectively. b2, c2 and d2 show the bottom surfaces of the 
channel, respectively; (e) The cross-sectional images at each region. The locations of the 
cross-sections were indicated as 1-1’, 2-2’, and 3-3’ in b1-d1, respectively. Scale bars: 
100 µm. 
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Figure. 3 The representative immunofluorescent confocal images demonstrated 
the VE-Cadherin junctions formation throughout the entire network. (a) The 
schematic image of the network with selected regions as shown in b-d; (b-c) VE-Cadherin 
and cell nuclei staining were shown at the first and third branching regions; (d1-d2) VE-
Cadherin and cell nuclei staining were shown at the top and bottom surfaces of the 
second branching regions, respectively; (e) Enlarged region indicated in (a). Scale bars: 
100 µm 
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Figure. 4 HUVECs response to the different levels of shear stresses: The 
morphology change was studied with F-actin staining. (a) The schematic image of 
the network with the indicated selected region for shear stress test; (b) COMSOL 
simulation shows the wall shear stress distribution in the selected region along the 
network. (c-e) Confocal image showed the F-actin stress fibers under the LSC-LST, LSC-
HST, and HSC-HST respectively. (f) Aspect ratio comparing between the three testing 
groups; (g) Comparing of the cell surface areas between the testing groups; All data are 
reported as the means ± SE of independent experiment. Scale bars: 100 µm. *: P<0.05; 
**: P<0.01; ***: P<0.001. 
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Figure 5 ATP-induced endothelial cell [Ca2+]i increase in HUVECs cultured 
microchannel network. (a) Time course of ATP-induced changes in endothelial [Ca2+]i 
from a representative experiment; (b) Fluo-4 confocal images from one representative 
experiment before and after the start of ATP perfusion at 60 and 160 seconds. 
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Fig. 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 ATP-induced NO production increases in HUVECs cultured microchannel 
network. (a) Time dependent changes in FIDAF (left Y axis) from a representative 
experiment before and after ATP (10 µM) stimulation with continuous perfusion of DAF-2 
DA at 5 μM. The 1st differential conversion of cumulative FIDAF (df /dt, right Y axis) 
represents the NO production rate (dash-dotted line); (b) Representative DAF-2 
fluorescence images. ATP induced significant increases in nitric oxide (NO)-DAF-2 
fluorescence intensity (FI) relative to control (left). FI was further increased with the 
application of the NO donor sodium nitroprusside (SNP). 
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CHAPTER 6 
GENERAL DISCUSSION, CONCLUSION AND FUTURE STUDIES 
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GENERAL DISCUSSION AND CONCLUSION 
Unchecked increase in microvessel permeability can lead to a variety of cardiovascular 
diseases. A deep and integrative understanding of the mechanisms of NO and shear stress 
participating in the regulation of microvascular permeability could provide new perspective 
into those diseases, which may eventually contribute to inventing potential therapeutic 
strategies. 
The role of NO in regulating microvessel permeability has been debated for more than 
a decade. The study in Chapter 2 demonstrated for the first time that exogenously applied 
AP-CAV, a specific eNOS inhibitor, has been shown to not only inhibit inflammatory 
stimulus-induced increases in NO production and microvessel permeability,1-3 but also 
reduce basal NO production in endothelial cells lining microvessel walls. Furthermore, the 
study suggested that reducing basal NO by AP-CAV did not directly change basal 
microvessel permeability, but it increased the adhesive capacity of endothelial cells and 
promotes leukocyte adhesion via Src-mediated phosphorylation of ICAM-1. Meanwhile, a 
NO donor, SNP, abolished the effect of AP-CAV on increased ICAM-1 binding to a blocking 
antibody and leukocyte adhesion, and further supported that the anti-adhesive property of 
basal NO in maintaining the homeostasis of vascular walls.  
In addition to the mechanism of CAV-induced leukocyte adhesion, we found that CAV-
induced leukocytes adhesion does not increase microvessel permeability, which was 
further approved by the observation of the intact and continuous VE-cadherin on 
endothelial junction. Previously, our study showed that TNF-α-induced leukocyte adhesion 
and migration are not sufficient to cause increases in microvessel permeability.4 Although 
the interaction of leukocytes with endothelial cells has been considered as the critical event 
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leading to permeability increase, there are also increasing evidences demonstrating the 
dissociation between leukocyte adhesion and changes in permeability.5, 6 Studies in rat 
tracheal mucosa found that 94% of the gap junctions were distinct from sites of leukocyte 
adhesion or migration in the leaky venules. 7, 8 Valeski et al demonstrated that blocking 
histamine-associated adherent leukocytes had no significant effect on leakage formation.9 
Furthermore, previous studies from our lab and others suggested that it is the additional 
stimuli that induced leukocyte oxidative burst which, in turn, are responsible for the 
increased microvessel permeability. 4, 10-13 Our previous study demonstrated that fMLP-
induced ROS production in adhered leukocytes to vascular wall was one of the 
mechanisms responsible  for the increased permeability in TNF-α primed rat mesenteric 
venules.10 In further support of this hypothesis, in the current study, we observed a transient 
increase in microvessel permeability only upon fMLP (10 μM) perfusion in the presence of 
AP-CAV-induced adherent leukocytes. Our finding that AP-CAV-induced leukocytes 
adhesion does not increase permeability consolidates the theory that adhesive interactions 
between leucocytes and endothelial cells is independent from the potential endothelial 
damage caused by leukocyte ROS release and therefore is dissociated from increases in 
microvessel permeability. 
Other than chemical stimulation, mechanical force stimulation also has been suggested 
play an important role in the regulation of microvessel permeability. Wall SS is the 
tangential force exerted per unit area of the blood-endothelium surface. Post-capillary 
venules are the main sites where the permeability increase and recruitment of leukocytes 
occur during inflammation. Only a few in vivo studies investigating whether the shear stress 
(by either increase perfusion pressure or shear rate) affect microvessel Lp in frog or rat 
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mesentery venules.14-16 Unfortunately, these studies provide contradicting results. In those 
studies, none of them involving blood cell components, which are always present in the 
blood stream. Our results in Chapter 3 indicated that in intact venules ATP released from 
RBCs in response to a sudden change of SS is responsible for the increases in EC [Ca2+]i 
and vascular permeability, whereas SS-induced EC NO production can be independent of 
increased EC [Ca2+]i. It may provide the basic mechanisms that help to explain and predict 
the roles of acute changes in SS in different vasculature under both physiological and 
pathological conditions. Under physiological condition, variations in vascular geometry 
could cause the RBCs experienced high SS at small vessel region, which may release 
increased amount of ATP and cause increases in EC [Ca2+]i and gap formation at 
downstream vessels. Under pathological conditions, such as vascular lumen narrowing due 
to the atherosclerotic plaque formation, or injury-induced local cell proliferation, sudden 
increases in SS and increased ATP release may dramatically affect the downstream vessel 
segment permeability and exaggerate the local inflammation.  
Other than the question we discussed in Chapter 3: ‘How blood flow-generated shear 
stress regulates microvessel permeability?’, another mystery waiting for resolving is ‘how 
endothelial cells sense the shear stress?’. Up to now, there are several mechanosensor 
candidates have been proposed, such as ion channels,17 G-protein-coupled receptors 
(GPCRs), 18 caveolae, 19 adhesion proteins,20 and the glycocalyx.21 The glycocalyx is a 
layer of proteoglycans covering the endothelium. It has been indicated to be a 
mechanotransduction sensor for changes of shear stress.22 An impaired glycocalyx has 
been suggested to contribute to the increased leukocyte adhesion, hyperpermeability, and 
other microvascular dysfunctions associated with diabetes and other cardiovascular 
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diseases. In Chapter 4, we found the impaired glycocalyx increases the endothelial 
susceptibility to shear stress, which augmented NO production in microvessels of diabetic 
rats. Similar enhanced NO production has also been found in pronase treated normal 
vessel. The results implicates that glycocalyx may serves to reduce the fluid shear stress 
at the surface of the membrane where most receptors are located that could serve as 
mechanosensor. 
Besides in vivo study of microvessel, in Chapter 5, we demonstrated in vitro formation 
of a microvessel network that recapitulates key features of microvessels in vivo and validate 
its utility for biological applications. Microfluidic model has been indicated could have a 
great potential for biological applications and bridging the gaps between in vitro and in vivo 
microvascular research. Comparing to other conventional in vitro models, our model is 
more physiological relevant. Firstly, endothelialized microchannels are under flow control, 
which mimics microscaled dimensions of in vivo microvessels with continuous flow. 
Secondly, immunofluorescence staining of VE-cadherin and F-actin demonstrated the 
formation of vascular endothelial junctions and well developed cytoskeleton, two important 
characters indicating well-maintained endothelial barrier functions. Thirdly, engineered 
microvessels EC transient [Ca2+]i responses and increased NO production in response to 
agonist application are similar to those observed in individually perfused intact 
microvessels. Overall, it suggested that the developed microvessel model has the potential 
to bridge the gap between over-simplified in vitro tests and more expensive and labor-
intensive in vivo animal models for the microvascular signaling and functional studies. Also, 
by culturing an individual human subject’s cells or perfusing human subject’s blood or fluid, 
it offers valuable clinical significance under both physiological and pathological conditions. 
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Overall, this dissertation demonstrated the important role of basal NO in the regulation 
of microvessel permeability and leukocyte adhesion, the critical role of blood flow generated 
shear stress in endothelial cell signaling and microvessel permeability in vivo, the effect of 
impaired glycocalyx in diabetic rat venules in its response to shear stress, and also the 
potential usage of microfluidic devices in microvascular research. 
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SIGNIFICANCE OF THE STUDY 
Despite years of studies, the exact roles of NO in the regulation of microvessel 
permeability remain controversial. The study in Chapter 2 was conducted in intact 
microvessels under basal conditions. Combined with our previous findings on inflammatory 
stimuli-induced NO and microvessel permeability, 1-3, 23 we revealed dual actions of NO on 
endothelial functions using the same experimental preparation, but under different 
conditions, which provides a unified perspective of the roles of NO in the regulation of 
endothelial function and microvessel permeability. 
Previous studies of the effects of SS on vascular endothelium were mainly conducted 
in the absence of blood cell components either in cultured endothelial monolayers 24, 25 or 
in individually perfused microvessels.14-16  Whereas the studies of the effects of shear on 
blood cells, such as RBCs, usually do not involve vascular endothelium.26-28 Our studies by 
direct comparisons of intact microvascular responses to SS generated by uniform fluids, 
such as plasma or solutions containing Dextran 70, with SS generated by blood flow 
demonstrated that under physiological conditions, i.e. in blood perfused microvessels, the 
changes of blood flow affect endothelium not only by fluid-generated wall SS, but also by 
shear-induced ATP release from RBCs. Our results in Chapter 3 indicated that an increase 
of fluid-generated wall SS induces increased endothelial cell NO production, which does 
not involve an increase in endothelial [Ca2+]i. However, under in vivo conditions, i.e. in blood 
perfused vessels, the increased shear exerted on RBCs induces shear-magnitude 
dependent ATP release. This SS-dependent ATP release from RBCs causes increases in 
endothelial [Ca2+]i and endothelial gap formation, an indication of increases in microvessel 
permeability. By linking the effects of wall SS on endothelium with the effects of shear 
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induced ATP release from RBCs on endothelium, our study provided new insight about 
how changes of blood flow affect vascular functions in vivo.  
Most of the experiments in our study have been conducted in individually perfused 
microvessels with undisturbed surrounding circulation, which we consider extremely 
important. In order to translate the remarkable knowledge gained from in vitro studies into 
clinical therapeutic applications, it is essential to evaluate cellular and molecular 
mechanisms in their native state. Multidimensional protein identification revealed that 41% 
of proteins expressed in vivo are not detected in vitro, indicating that distinct in vivo protein 
expression is apparently regulated by the tissue microenvironment and cannot yet be 
duplicated in standard cell culture.29 This is specifically important for glycocalyx studies, 
because the glycocalyx under static cultured cell growth is not as well developed as that 
under physiological conditions. 30 
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FUTURE STUDIES 
The dissertation has demonstrated that NO and SS play important roles in the regulation 
of microvessel permeability. There are still many questions worth further exploration.  
In Chapter 2, the timing of rapid increased ICAM-1 staining induced by AP-CAV 
perfusion ruled out the possibility of new ICAM-1 protein synthesis. However, our results 
could not enable us to rule out the possibility of membrane translocation of ICAM-1 in 
response to AP-CAV-induced NO reduction. TNF-α-induced early phase leukocyte 
adhesion involves the activation of constitutive ICAM-1 on cell surface, which is 
demonstrated by protein analysis from cytoplasmic and membrane fractions in cultured 
cells. 31 In order to pursue the detailed molecular mechanism of AP-CAV induced rapid 
increase of EC ICAM-1 affinity to leukocyte, with collaboration with an in vitro research 
group, we are going to first verify our finding on cultured cells and then using western 
blotting, Real time PCR and other molecular techniques to study the change of EC ICAM-
1 from both cytosol and cell membrane upon the stimulation of AP-CAV. 
In Chapter 3, we found both plasma and blood-generated shear stress induced shear-
magnitude dependent EC NO production increase. Interestingly, plasma perfusion 
generated change of shear stress caused more EC production than that of blood perfusion. 
However, eNOS ser1177 and Thr495 immunofluorescence staining revealed that blood 
perfusion resulted in same extent of eNOS activation as plasma did. We hypothesized that 
it may due to hemoglobin in the RBCs scavenge the EC NO induced by the blood perfusion. 
To test this hypothesis, we could use CO to uncover role of NO binding to hemoglobin. We 
could perfuse carbon monoxide blood into our microvessel to see whether it generated 
more EC NO production than that of blood perfusion. 
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Also, in Chapter 3, we used carbenoxolone to test our hypothesis that Pannexin 1 
channel is the one responsible for the ATP releasing from RBCs triggered by shear stress. 
Carbenoxolone is an unspecific gap junction blocker, and has been demonstrated strongly 
inhibited Pannexin 1 ((IC50 = 5 μm).32 Other than ubiquitously expressed Pannexin 1 
channel, Pannexin family also has Pannexin 2, and Pannexin 3 channel as its family 
members. Pannexin 1 was first demonstrated to act as an ATP-permeant channel on RBCs 
in 2006. 33 In order to rule out the Pannexin 2 and Pannexin 3’s possibilities involving in 
shear stress induced ATP releasing from RBCs, we would further investigate the role of 
Pannexin 1 channel using Pannexin 1 channel genetic knockout mice.   
The glycocalyx has been indicated as a mechanotransduction sensor to the fluid shear 
stress in many in vitro studies.22, 34-36 Using enzyme degradation of its specific components 
impaired the shear stress induced NO production and increased permeability in vitro.37 In 
Chapter 4, our results suggested that loss or impaired EC glycocalyx enhanced EC NO 
production to shear stress. Based on the cell culture studies, removing hyaluronic acid 
(HA), sialic acids (SA), heparin sulfate (HS) but not chondroitin sulfate (CS) abolished NO 
production.38 Some studies reported that removing HA, HS, CS blocked shear-induced 
increases in Lp. Our future study will use glycocalyx component-specific enzymes 
individually or in combination to degrade the glycocalyx, which enable us to differentiate 
the roles of different glycocalyx components in shear stress-induced NO production in intact 
microvessels. Meanwhile, since NO is an important regulator in microvessel permeability 
and leukocyte adhesion. It is also interesting to investigate the role of glycocalyx in 
microvessel permeability and leukocyte adhesion. 
  
  
 
 
171 
 
REFERENCE 
1. Zhou X, He P. Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS 
activity and microvessel permeability in rat venules. Cardiovasc Res. 
2010;87(2):340-347. 
2. Zhou X, He P. Temporal and spatial correlation of platelet-activating factor-induced 
increases in endothelial [Ca(2)(+)]i, nitric oxide, and gap formation in intact venules. 
Am J Physiol Heart Circ Physiol. 2011;301(5):H1788-1797. 
3. Zhu L, Schwegler-Berry D, Castranova V, He P. Internalization of caveolin-1 
scaffolding domain facilitated by Antennapedia homeodomain attenuates PAF-
induced increase in microvessel permeability. Am J Physiol Heart Circ Physiol. 
2004;286(1):H195-201. 
4. Zeng M, Zhang H, Lowell C, He P. Tumor necrosis factor-alpha-induced leukocyte 
adhesion and microvessel permeability. Am J Physiol Heart Circ Physiol. 
2002;283(6):H2420-2430. 
5. He P. Leucocyte/endothelium interactions and microvessel permeability: coupled or 
uncoupled? Cardiovasc Res.87(2):281-290. 
6. Harris NR, Benoit JN, Granger DN. Capillary filtration during acute inflammation: 
role of adherent neutrophils. Am J Physiol. 1993;265(5 Pt 2):H1623-1628. 
7. McDonald DM. Endothelial gaps and permeability of venules in rat tracheas exposed 
to inflammatory stimuli. Am J Physiol. 1994;266(1 Pt 1):L61-83. 
8. Baluk P, Bolton P, Hirata A, Thurston G, McDonald DM. Endothelial gaps and 
adherent leukocytes in allergen-induced early- and late-phase plasma leakage in rat 
airways. Am J Pathol. 1998;152(6):1463-1476. 
9. Valeski JE, Baldwin AL. Effect of early transient adherent leukocytes on venular 
permeability and endothelial actin cytoskeleton. Am J Physiol. 1999;277(2 Pt 
2):H569-575. 
10. Zhu L, He P. fMLP-stimulated release of reactive oxygen species from adherent 
leukocytes increases microvessel permeability. Am J Physiol Heart Circ Physiol. 
2006;290(1):H365-372. 
11. Zhu L, Castranova V, He P. fMLP-stimulated neutrophils increase endothelial 
[Ca2+]i and microvessel permeability in the absence of adhesion: role of reactive 
oxygen species. Am J Physiol Heart Circ Physiol. 2005;288(3):H1331-1338. 
12. Tinsley JH, Ustinova EE, Xu W, Yuan SY. Src-dependent, neutrophil-mediated 
vascular hyperpermeability and beta-catenin modification. Am J Physiol Cell 
Physiol. 2002;283(6):C1745-1751. 
13. Jakus Z, Berton G, Ligeti E, Lowell CA, Mocsai A. Responses of neutrophils to anti-
integrin antibodies depends on costimulation through low affinity Fc gamma Rs: full 
  
 
 
172 
 
activation requires both integrin and nonintegrin signals. J Immunol. 
2004;173(3):2068-2077. 
14. Neal CR, Bates DO. Measurement of hydraulic conductivity of single perfused Rana 
mesenteric microvessels between periods of controlled shear stress. J Physiol. 
2002;543(Pt 3):947-957. 
15. Williams DA. A shear stress component to the modulation of capillary hydraulic 
conductivity (Lp). Microcirculation. 1996;3(2):229-232. 
16. Adamson RH, Sarai RK, Altangerel A, Clark JF, Weinbaum S, Curry FE. 
Microvascular permeability to water is independent of shear stress, but dependent 
on flow direction. Am J Physiol Heart Circ Physiol. 2013;304(8):H1077-1084. 
17. Olesen SP, Clapham DE, Davies PF. Haemodynamic shear stress activates a K+ 
current in vascular endothelial cells. Nature. 1988;331(6152):168-170. 
18. Gudi SR, Clark CB, Frangos JA. Fluid flow rapidly activates G proteins in human 
endothelial cells. Involvement of G proteins in mechanochemical signal 
transduction. Circ Res. 1996;79(4):834-839. 
19. Rizzo V, Morton C, DePaola N, Schnitzer JE, Davies PF. Recruitment of endothelial 
caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J 
Physiol Heart Circ Physiol. 2003;285(4):H1720-1729. 
20. Osawa M, Masuda M, Kusano K, Fujiwara K. Evidence for a role of platelet 
endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: 
is it a mechanoresponsive molecule? J Cell Biol. 2002;158(4):773-785. 
21. Tarbell JM, Pahakis MY. Mechanotransduction and the glycocalyx. J Intern Med. 
2006;259(4):339-350. 
22. Weinbaum S, Zhang X, Han Y, Vink H, Cowin SC. Mechanotransduction and flow 
across the endothelial glycocalyx. Proc Natl Acad Sci U S A. 2003;100(13):7988-
7995. 
23. Zhu L, He P. Platelet-activating factor increases endothelial [Ca2+]i and NO 
production in individually perfused intact microvessels. Am J Physiol Heart Circ 
Physiol. 2005;288(6):H2869-2877. 
24. Sill HW, Chang YS, Artman JR, Frangos JA, Hollis TM, Tarbell JM. Shear stress 
increases hydraulic conductivity of cultured endothelial monolayers. Am J Physiol. 
1995;268(2 Pt 2):H535-543. 
25. Pang Z, Antonetti DA, Tarbell JM. Shear stress regulates HUVEC hydraulic 
conductivity by occludin phosphorylation. Ann Biomed Eng. 2005;33(11):1536-
1545. 
26. Edwards J, Sprung R, Sprague R, Spence D. Chemiluminescence detection of ATP 
release from red blood cells upon passage through microbore tubing. Analyst. 
2001;126(8):1257-1260. 
  
 
 
173 
 
27. Forsyth AM, Wan J, Owrutsky PD, Abkarian M, Stone HA. Multiscale approach to 
link red blood cell dynamics, shear viscosity, and ATP release. Proc Natl Acad Sci 
U S A.108(27):10986-10991. 
28. Wan J, Ristenpart WD, Stone HA. Dynamics of shear-induced ATP release from red 
blood cells. Proc Natl Acad Sci U S A. 2008;105(43):16432-16437. 
29. Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, Testa JE, Oh P, Schnitzer JE. 
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo 
and in cell culture. Nat Biotechnol. 2004;22(8):985-992. 
30. Barakat AI. Dragging along: the glycocalyx and vascular endothelial cell 
mechanotransduction. Circ Res. 2008;102(7):747-748. 
31. Javaid K, Rahman A, Anwar KN, Frey RS, Minshall RD, Malik AB. Tumor necrosis 
factor-alpha induces early-onset endothelial adhesivity by protein kinase Czeta-
dependent activation of intercellular adhesion molecule-1. Circ Res. 
2003;92(10):1089-1097. 
32. Bruzzone R, Barbe MT, Jakob NJ, Monyer H. Pharmacological properties of 
homomeric and heteromeric pannexin hemichannels expressed in Xenopus 
oocytes. J Neurochem. 2005;92(5):1033-1043. 
33. Locovei S, Bao L, Dahl G. Pannexin 1 in erythrocytes: function without a gap. Proc 
Natl Acad Sci U S A. 2006;103(20):7655-7659. 
34. Mulivor AW, Lipowsky HH. Role of glycocalyx in leukocyte-endothelial cell adhesion. 
Am J Physiol Heart Circ Physiol. 2002;283(4):H1282-1291. 
35. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial 
glycocalyx: composition, functions, and visualization. Pflugers Arch. 
2007;454(3):345-359. 
36. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial 
glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121-167. 
37. Mochizuki S, Vink H, Hiramatsu O, Kajita T, Shigeto F, Spaan JA, Kajiya F. Role of 
hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric 
oxide release. Am J Physiol Heart Circ Physiol. 2003;285(2):H722-726. 
38. Pahakis MY, Kosky JR, Dull RO, Tarbell JM. The role of endothelial glycocalyx 
components in mechanotransduction of fluid shear stress. Biochem Biophys Res 
Commun. 2007;355(1):228-233. 
 
 
 
  
 
 
174 
 
CURRICULUM VITAE 
Sulei Xu 
Research Assistant 
West Virginia University, School of Medicine, Department of Physiology and Pharmacology 
One Medical Center Drive, HSN-3068, WV 26506 
Cell 304-906-6514 
Email: sxu1@mix.wvu.edu 
 
EDUCATION 
 PhD in Cellular and integrative physiology      
1/2009 to 10/2014 (expected), West Virginia University, Morgantown, WV 
 B.S. in Bioengineering               
9/2004 to 7/2008, Shanghai University, Shanghai, China 
 
PROFESSIONAL EXPERIENCE  
 Research Assistant 
West Virginia University, Department of Physiology and Pharmacology, School of Medicine, 
1/2009 to date, supervised by Dr. Ping He 
Project 1: Differentiate the roles of endogenous endothelial S1P subtype 
receptors in  the regulation of permeability in intact microvessels 
Project 2: Investigate the roles of exogenously applied caveolin-1 peptide in 
endothelial basal nitric oxide production, ICAM-1 expression, 
leukocyte adhesion, and adhesion-induced changes in microvessel 
permeability 
Project 3: Investigate cellular and molecular mechanisms of how shear stress 
regulates microvessel functions under physiological and pathological 
conditions 
Project 4: Investigate the enhanced permeability responses to inflammation in 
streptozotocin-induced diabetic rat venules: Rho-mediated 
alterations of actin cytoskeleton and VE-cadherin 
Project 5: Investigate endothelial nitric oxide and calcium response to ATP in 
microfluidic device 
 
 Research Assistant 
Shanghai University, School of Life Science, 8/2007 to 12/2008, supervised by Dr. Fuxue Chen 
Project 1: Investigate the structure, Function and Modulation of KATP 
Channels (in responsible for aortic ring organ bath vascular 
function assay) 
Project 2: Down-regulation of 67LR reduces the migratory activity of Human 
Glioma Cell ( involving in cell culture, plasmid siRNA transfection 
and wound-healing assay) 
 
PUBLICATIONS 
 Xu, S, Yokota, S, He, P. Shear stress induced ATP release from erythrocytes increases 
  
 
 
175 
 
endothelial calcium and vascular permeability in intact rat venules. (In preparation) 
 Xu, S, Yuan, D and He, P. The impaired glycocalyx increases the endothelial susceptibility to 
shear stress resulting in augmented nitric oxide production in microvessels of diabetic rats. (In 
preparation) 
 Li, X*, Xu, S*, He, P, Liu, Y. In Vitro Recapitulation of Functional Microvessels for the Study of 
Endothelial Shear Response, Nitric Oxide and [Ca2+]i . (Submitted, *Shared first authorship) 
 Yuan, D, Xu, S and He, P. Enhanced permeability responses to inflammation in streptozotocin-
induced diabetic rat venules: Rho-mediated alterations of actin cytoskeleton and VE-cadherin. 
Am J Physiol Heart Circ Physiol. 2014, 307(1):H44-H53. 
 Xu, S, Zhou, X, Yuan, D, Xu, Y and He, P. Caveolin-1 scaffolding domain promotes leukocyte 
adhesion by reduced basal endothelial nitric oxide-mediated ICAM-1 phosphorylation in rat 
mesenteric venules. Am J Physiol Heart Circ Physiol. 2013, 305(10):H1484-93.  
 Zhang, G, Xu, S. Qian, Y and He, P. Sphingosine 1-phosphate (S1P) prevents permeability 
increases via activation of endothelial S1P receptor 1 in rat venules. Am J Physiol Heart Circ 
Physiol, 2010, 299(5): H1494-1504  
 Chen, F, Ren, W, Yang, Y, Shen, D, Zong, Y, Xu, S, Di, S, Qian Y and Ji, Y. Reciprocal effects 
of conditioned medium on cultured glioma cells and neural stem cells. Journal of Clinical 
Neuroscience. 2009, (12):1619–1623 
 Duan, Y, Ren, W, QIAN ,Y, Zheng, D, Xu, Y, Zong, Y, Xu, S and Chen, F. Down-regulation of 
67LR Reduces the Migratory Activity of Human Glioma Cell, Acta Agriculturae Boreali-
Occidentalis Sinica, 2008, (04):52-57 
 
ABSTRACTS 
 Xu, S and He, P. Changing shear stress-induced ATP release from erythrocytes increases 
endothelial calcium and vascular permeability independent from nitric oxide production in intact 
rat venules. FASEB, 2014   
 Petrides, P, Tan, Z, Xu, S, Guo, G, Huber, J, Rosen, C and He, P. Ischemic stroke-induced 
increases in circulating microparticles promote leukocyte adhesion in intact microvessels. 
FASEB, 2014. 
 Xu, S and He, P. The impaired glycocalyx increases the endothelial susceptibility to shear stress 
resulting in augmented nitric oxide production in microvessels of diabetic rats. FASEB, 2013   
 Xu, S, Yuan, D and He, P. Shear stress-induced differential endothelial signaling and changes 
in microvessel permeability in the presence and absence of erythrocytes in intact rat venules. 
Vascular Biology, 2013.   
 Yuan, D, Wang, M, Xu, S and He, P. Time course of changes in microvessel permeability in 
streptozotocin (STZ)-induced diabetic rats. FASEB, 2013.   
 Xu, S, Yuan, D, He, P. Shear stress generated by different fluid compositions induces differential 
endothelial signaling in intact venules. FASEB, 2012. 
 Xu, S, Zhou, X, Yuan, D, Xu, Y and He, P. Caveolin-1 scaffolding domain induces leukocyte 
  
 
 
176 
 
adhesion without increasing permeability in intact rat mesenteric venules. FASEB, 2011. 
 Yuan, D, Zhou, X, Xu, S, He, P. Streptozotocin-Induced Diabetes Enhances Microvessel 
Permeability Responses to Acutely Applied Inflammatory Mediator in Rat Mesenteric Venules. 
FASEB, 2011. 
 
AWARDS AND FELLOWSHIP 
 2014 Award for selected Oral presentation, Van Liere Convocation, School of Medicine, West 
Virginia University, Morgantown, USA 
 2014 E.J. Van Liere Memorial Convocation and Research Day Poster Presentation (First Place 
award), West Virginia University, Health Science Center 
 2013 Society for Experimental Biology and Medicine Young Investigator Award  
 2012 American Heart Association, Great River Affiliate Winter Predoctoral Fellowship 
(07/01/2012-06/30/2014) 
 2011 Benjamin Zweifach Graduate Student Travel Award in EB Poster section 
 2010 E.J. Van Liere Memorial Convocation and Research Day Poster Presentation (First Place 
award), West Virginia University, Health Science Center  
 2006-2007, First-Prize academic scholarship(merit based), Shanghai University, China 
 2005-2006, First-Prize academic scholarship(merit based), Shanghai University, China 
 2004-2005, Second-Prize academic scholarship(merit based),Shanghai University, China 
 
MEMBERSHIPS OF PROFESSIONAL ORGANIZATIONS 
 2013-present Student member of Society for Experimental Biology and Medicine  
 2012-present Student member of American Heart Association  
 2011-present Student member of American Physiology Society  
 2011-present Student member of Microcirculatory Society 
 
 
 
